var title_f30_5_30800="Pseudomonas empyema CT";
var content_f30_5_30800=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F66869&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F66869&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pseudomonas empyema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 322px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Large left sided empyema due to Pseudomonas aeruginosa. Posterior collection of pleural effusion compresses the left lung and displaces the cardiomediastinal silhouette to the right.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30800=[""].join("\n");
var outline_f30_5_30800=null;
var title_f30_5_30801="Endosc GOO prepylorus PUD";
var content_f30_5_30801=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F55405&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F55405&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gastric outlet obstruction due to peptic ulcer disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 317px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic view of the pre-pylorus in a patient with acute on chronic peptic ulcer disease and associated gastric outlet obstruction. The black arrow indicates the narrowed pylorus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Derek Frederickson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30801=[""].join("\n");
var outline_f30_5_30801=null;
var title_f30_5_30802="Patient information: Epilepsy and pregnancy (The Basics)";
var content_f30_5_30802=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?37/19/38194\">",
"         Patient information: Deciding to breastfeed (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?18/0/18434\">",
"         Patient information: EEG (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?42/40/43650\">",
"         Patient information: Epilepsy in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?37/1/37907\">",
"         Patient information: How to plan and prepare for a healthy pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?6/21/6483\">",
"         Patient information: Reducing the costs of medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/56/28546\">",
"         Patient information: Seizures (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?33/27/34229\">",
"         Patient information: Seizures in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Epilepsy and pregnancy (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/epilepsy-and-pregnancy-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H10157353\">",
"      <span class=\"h1\">",
"       What is epilepsy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Epilepsy is a condition that causes people to have repeated seizures. Seizures are waves of abnormal electrical activity in the brain. Seizures can make you pass out, or move or behave strangely.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10157368\">",
"      <span class=\"h1\">",
"       Can women with epilepsy have a normal pregnancy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Most women with epilepsy can have a healthy pregnancy.",
"     </p>",
"     <p>",
"      If you have epilepsy and want to have a baby, you will need to work closely with your doctors. They will make sure that you are doing the right things to control your epilepsy and protect your baby.",
"     </p>",
"     <p>",
"      More than 1 doctor will take care of you during pregnancy. One doctor will take care of your pregnancy. Your epilepsy doctor will take care of your epilepsy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10157383\">",
"      <span class=\"h1\">",
"       What should I do before trying to get pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It is very important to talk with your doctor",
"      <strong>",
"       before",
"      </strong>",
"      you try to get pregnant. That way, he or she has enough time to check your anti-seizure medicine and change it, if needed. That&rsquo;s because certain anti-seizure medicines and doses can harm an unborn baby.",
"     </p>",
"     <p>",
"      Your doctor might:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Change your anti-seizure medicine &ndash; He or she will make sure that your anti-seizure medicine is safe to take during pregnancy.",
"       </li>",
"       <li>",
"        Stop your anti-seizure medicine &ndash; If you have not had any seizures for 2 years, your doctor might talk with you about stopping your medicine. But don&rsquo;t ever stop an anti-seizure medicine on your own.",
"       </li>",
"       <li>",
"        Lower your dose of anti-seizure medicine",
"       </li>",
"       <li>",
"        Reduce the number of anti-seizure medicines you take (if you take more than 1)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      In addition to checking your medicine, your doctor might prescribe a vitamin called &ldquo;folate&rdquo; or &ldquo;",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?24/57/25492?source=see_link\">",
"       folic acid",
"      </a>",
"      .&rdquo; All women who are trying to get pregnant should take folate, because it helps prevent birth defects. Women who take certain anti-seizure medicines might need extra folate.",
"     </p>",
"     <p>",
"      There are also steps that all women should take before trying to get pregnant. (See",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/1/37907?source=see_link\">",
"       \"Patient information: How to plan and prepare for a healthy pregnancy (The Basics)\"",
"      </a>",
"      .)",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10157400\">",
"      <span class=\"h1\">",
"       How might my epilepsy affect my baby?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Having seizures while you are pregnant might harm your baby. If you fall down, you could hurt yourself and your baby. When you have a seizure, your baby might not get enough oxygen.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10157415\">",
"      <span class=\"h1\">",
"       Does pregnancy affect epilepsy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Not usually. Being pregnant will probably not make you have more seizures. But you could have more seizures if you don&rsquo;t follow your doctor&rsquo;s instructions and take your anti-seizure medicine (if you need medicine). &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10157430\">",
"      <span class=\"h1\">",
"       How can I lower my chances of having a seizure?",
"      </span>",
"      &nbsp;&mdash;&nbsp;To lower your chances of having a seizure, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Take your anti-seizure medicine exactly as directed &ndash; Do not stop or change your medicine without talking to your doctor. You might worry that your anti-seizure medicine will harm your baby. There is some chance that the medicine could do harm, but having a seizure can also harm your baby.",
"       </li>",
"       <li>",
"        Let your doctor know if you start any new prescription or non-prescription medicines, or herbal drugs",
"       </li>",
"       <li>",
"        Get enough sleep &ndash; Not getting enough sleep raises your chances of having a seizure.",
"       </li>",
"       <li>",
"        Eat a healthy diet",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10157445\">",
"      <span class=\"h1\">",
"       Will I have tests during pregnancy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You will have tests to check your baby&rsquo;s health. These can include blood tests and an imaging test called an ultrasound. An ultrasound creates pictures of your baby.",
"     </p>",
"     <p>",
"      You might also have blood tests to check the amount of anti-seizure medicine in your body.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10157460\">",
"      <span class=\"h1\">",
"       Can I have a normal vaginal delivery?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Most women can have a normal vaginal delivery. It is uncommon for women to have a seizure during delivery. Even so, your doctor will watch you closely during your delivery and adjust your medicine, if needed.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10157475\">",
"      <span class=\"h1\">",
"       Will my baby be healthy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your epilepsy was under control during your pregnancy, chances are very good that your baby will be healthy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10157490\">",
"      <span class=\"h1\">",
"       Will I be able to breastfeed?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Most women are able to breastfeed. If you want to breastfeed, talk with your doctor. He or she will make sure that your anti-seizure medicine is safe to take if you breastfeed.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10157505\">",
"      <span class=\"h1\">",
"       What else can I do to protect my baby?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have frequent seizures, there are things you can do to help keep your baby safe after he or she is born. You can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Change your baby&rsquo;s diaper on the floor &ndash; That way, if you have a seizure, your baby won&rsquo;t fall off a changing table.",
"       </li>",
"       <li>",
"        Have someone else with you when you bathe your baby &ndash; That way, your baby won&rsquo;t be alone in the bathtub if you have a seizure.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H10157527\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?42/40/43650?source=see_link\">",
"       Patient information: Epilepsy in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?18/0/18434?source=see_link\">",
"       Patient information: EEG (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/56/28546?source=see_link\">",
"       Patient information: Seizures (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/1/37907?source=see_link\">",
"       Patient information: How to plan and prepare for a healthy pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/19/38194?source=see_link\">",
"       Patient information: Deciding to breastfeed (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/21/6483?source=see_link\">",
"       Patient information: Reducing the costs of medicines (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?33/27/34229?source=see_link\">",
"       Patient information: Seizures in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?30/5/30802?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16570 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-50E636C042-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30802=[""].join("\n");
var outline_f30_5_30802=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10157353\">",
"      What is epilepsy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10157368\">",
"      Can women with epilepsy have a normal pregnancy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10157383\">",
"      What should I do before trying to get pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10157400\">",
"      How might my epilepsy affect my baby?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10157415\">",
"      Does pregnancy affect epilepsy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10157430\">",
"      How can I lower my chances of having a seizure?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10157445\">",
"      Will I have tests during pregnancy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10157460\">",
"      Can I have a normal vaginal delivery?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10157475\">",
"      Will my baby be healthy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10157490\">",
"      Will I be able to breastfeed?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10157505\">",
"      What else can I do to protect my baby?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10157527\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/19/38194?source=related_link\">",
"      Patient information: Deciding to breastfeed (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?18/0/18434?source=related_link\">",
"      Patient information: EEG (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?42/40/43650?source=related_link\">",
"      Patient information: Epilepsy in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?37/1/37907?source=related_link\">",
"      Patient information: How to plan and prepare for a healthy pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/56/28546?source=related_link\">",
"      Patient information: Seizures (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?33/27/34229?source=related_link\">",
"      Patient information: Seizures in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_5_30803="Smallpox rash";
var content_f30_5_30803=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F61772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F61772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Characteristics of smallpox",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 391px; height: 433px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patients with smallpox can have lesions on the palms or soles (A), umbilicated lesions (B), and confluent lesions (C). Panels D through F show days three, five, and seven in a young boy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from file://www.bt.cdc.gov/agent/smallpox/diagnosis/evalposter.asp.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30803=[""].join("\n");
var outline_f30_5_30803=null;
var title_f30_5_30804="Cephalexin: Pediatric drug information";
var content_f30_5_30804=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cephalexin: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?36/37/37462?source=see_link\">",
"    see \"Cephalexin: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?20/39/21108?source=see_link\">",
"    see \"Cephalexin: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F148610\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Keflex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F148611\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Cephalex&reg;;",
"     </li>",
"     <li>",
"      Dom-Cephalexin;",
"     </li>",
"     <li>",
"      Keflex&reg;;",
"     </li>",
"     <li>",
"      Novo-Lexin;",
"     </li>",
"     <li>",
"      Nu-Cephalex;",
"     </li>",
"     <li>",
"      PMS-Cephalexin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1046172\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Cephalosporin (First Generation)",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1046164\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?36/37/37462?source=see_link\">",
"      see \"Cephalexin: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children: 25-50 mg/kg/day divided every 6-8 hours; severe infections: 50-100 mg/kg/day divided every 6-8 hours; maximum dose: 4 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Otitis media: 75-100 mg/kg/day divided every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Streptococcal pharyngitis, skin and skin structure infections: 25-50 mg/kg/day divided every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocarditis prophylaxis: 50 mg/kg 1 hour prior to procedure (maximum: 2 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Uncomplicated cystitis: Children &gt;15 years: 500 mg every 12 hours for 7-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults: 250-500 mg every 6 hours; maximum dose: 4 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Streptococcal pharyngitis, skin and skin structure infections: 500 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocarditis prophylaxis: 2 g 1 hour prior to procedure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Uncomplicated cystitis: 500 mg every 12 hours for 7-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing interval in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-40 mL/minute: Administer every 8-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: Administer every 12-24 hours",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F148585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral: 250 mg, 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Keflex&reg;: 250 mg, 500 mg, 750 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for suspension, oral: 125 mg/5 mL (100 mL, 200 mL); 250 mg/5 mL (100 mL, 200 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 250 mg, 500 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F148569\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1046176\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Administer on an empty stomach (ie, 1 hour prior to, or 2 hours after meals); administer with food if GI upset occurs; shake suspension well before use",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet for oral suspension: Mix tablet in a small amount of water (&sim;10 mL); stir until thoroughly mixed; entire mixture should be administered immediately after mixing; rinse container with an additional small amount of water and drink contents to assure the whole dose is taken.",
"     <b>",
"      Do not",
"     </b>",
"     chew or swallow tablets.",
"     <b>",
"      Do not",
"     </b>",
"     mix with liquids other than water.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1046168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refrigerate suspension after reconstitution; discard after 14 days; tablets for oral suspension should be used immediately after dissolving",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1046175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of susceptible bacterial infections, including those caused by group A beta-hemolytic",
"     <i>",
"      Streptococcus",
"     </i>",
"     ,",
"     <i>",
"      Staphylococcus",
"     </i>",
"     ,",
"     <i>",
"      Klebsiella pneumoniae",
"     </i>",
"     ,",
"     <i>",
"      E. coli",
"     </i>",
"     , and",
"     <i>",
"      Proteus mirabilis",
"     </i>",
"     ; not active against enterococci or methicillin-resistant staphylococci; used to treat susceptible infections of the respiratory tract, skin and skin structure, bone, genitourinary tract, and otitis media; alternative therapy for endocarditis prophylaxis",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F148636\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Cephalexin may be confused with cefaclor, ceFAZolin, ciprofloxacin",
"      </p>",
"      <p style=\"text-indent:0em;margin-left:2em;text-align:justify;\">",
"       Keflex&reg; may be confused with Keppra&reg;, Valtrex&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F148634\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, confusion, dizziness, fatigue, hallucinations, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Angioedema, erythema multiforme (rare), rash, Stevens-Johnson syndrome (rare), toxic epidermal necrolysis (rare), urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, diarrhea, dyspepsia, gastritis, nausea (rare), pseudomembranous colitis, vomiting (rare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Genital pruritus, genital moniliasis, vaginitis, vaginal discharge",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Eosinophilia, hemolytic anemia, neutropenia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: ALT increased, AST increased, cholestatic jaundice (rare), transient hepatitis (rare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, arthritis, joint disorder",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Interstitial nephritis (rare)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions, anaphylaxis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1046179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to cephalexin, any component, or cephalosporins",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1046163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution and modify dosage in patients with renal impairment; use with caution in patients with history of colitis or history of penicillin hypersensitivity. Tablets for oral suspension contain aspartame which is metabolized to phenylalanine and must be avoided (or used with caution) in patients with phenylketonuria.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1046162\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prolonged use may result in GI or genitourinary superinfection; do not use in patients with immediate-type hypersensitivity reactions to penicillin",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299003\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F148578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MetFORMIN: Cephalexin may increase the serum concentration of MetFORMIN.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May decrease the serum concentration of Cephalexin. Specifically, the zinc contained in many multivitamins may decrease cephalexin absorption. Management: Consider administering multivitamins at least 3 hours after cephalexin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Cephalosporins.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Cephalosporins may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zinc Salts: May decrease the absorption of Cephalexin. Management: Consider administering oral zinc salts at least 3 hours after cephalexin.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Zinc Chloride.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1046180\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food may delay absorption",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F148581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F3017197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. Cephalexin crosses the placenta and produces therapeutic concentrations in the fetal circulation and amniotic fluid. An increased risk of teratogenic effects has not been observed following maternal use of cephalexin. Peak concentrations in pregnant patients are similar to those in nonpregnant patients. Prolonged labor may decrease oral absorption.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1046171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     With prolonged therapy, monitor renal, hepatic, and hematologic function periodically; number and type of stools/day for diarrhea",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1046161\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins; inhibits the final transpeptidation step of peptidoglycan synthesis resulting in cell wall death",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1046178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Rapid (90%); delayed in young children and may be decreased up to 50% in neonates",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Into tissues and fluids including bone, pleural and synovial fluid; crosses the placenta; appears in breast milk",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 6% to 15%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neonates: 5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 3-12 months: 2.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 0.5-1.2 hours (prolonged with renal impairment)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Oral: Within 60 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: 80% to 100% of dose excreted as unchanged drug in urine within 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: Moderately dialyzable (20% to 50%)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1046170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?20/39/21108?source=see_link\">",
"      see \"Cephalexin: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Counsel patient that cephalexin should only be used to treat bacterial infections. Entire course of medication should be taken even if patient feels better early in the course. Report prolonged diarrhea.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bergan T, &ldquo;Pharmacokinetic Properties of Cephalosporins,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1987, 34 (Suppl 2):89-104.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?30/5/30804/abstract-text/3319507/pubmed\" id=\"3319507\" target=\"_blank\">",
"        3319507",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bradley JS, Byington CL, Shah SS, et al, &ldquo;The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America&rdquo;,",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2011, 53(7):e25-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?30/5/30804/abstract-text/21880587/pubmed\" id=\"21880587\" target=\"_blank\">",
"        21880587",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shulman ST, Bisno AL, Clegg HW, et al, \"Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2012.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?30/5/30804/abstract-text/22965026/pubmed\" id=\"22965026\" target=\"_blank\">",
"        22965026",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13138 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-201.77.166.39-2FACFC3B1A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30804=[""].join("\n");
var outline_f30_5_30804=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148610\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148611\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046172\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046164\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148585\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148569\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046176\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046168\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046175\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148636\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148634\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046179\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046163\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046162\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299003\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148578\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046180\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148581\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3017197\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046171\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046161\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046178\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1046170\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13138\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13138|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?36/37/37462?source=related_link\">",
"      Cephalexin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?20/39/21108?source=related_link\">",
"      Cephalexin: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_5_30805="Tramadol: Patient drug information";
var content_f30_5_30805=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Tramadol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/50/42792?source=see_link\">",
"     see \"Tramadol: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?26/7/26743?source=see_link\">",
"     see \"Tramadol: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F229623\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      ConZip&trade;;",
"     </li>",
"     <li>",
"      Rybix&trade; ODT;",
"     </li>",
"     <li>",
"      Ryzolt&trade;;",
"     </li>",
"     <li>",
"      Ultram&reg;;",
"     </li>",
"     <li>",
"      Ultram&reg; ER",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F229624\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Durela&trade;;",
"     </li>",
"     <li>",
"      Ralivia&trade;;",
"     </li>",
"     <li>",
"      Tridural&trade;;",
"     </li>",
"     <li>",
"      Ultram&reg;;",
"     </li>",
"     <li>",
"      Zytram&reg; XL",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10024974\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024976\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024975\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to tramadol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are addicted to drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701044",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink beer, wine, or mixed drinks or take any drugs that have alcohol.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024980\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697135",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a history of a drug or drinking problem, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have PKU, talk with your doctor. Some products have phenylalanine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697176",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have tried to take your own life, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024981\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699003",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Seizures.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699000",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Poor pain control.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024978\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         All products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a pain diary.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696422",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Long-acting products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695714",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696157",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Ultram&reg; ER: Always take with food or always take on an empty stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705488",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral-disintegrating tablet:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694164",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not push the tablet out of the foil when opening. Use dry hands to take it from the foil. Place on your tongue and let it melt. Water is not needed. Do not swallow it whole. Do not chew, break, or crush it.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024979\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024984\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11889 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-83.177.194.223-4E972C53F8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30805=[""].join("\n");
var outline_f30_5_30805=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229623\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229624\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024974\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024976\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024975\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024980\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024981\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024983\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024978\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024979\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024984\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024985\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?41/50/42792?source=related_link\">",
"      Tramadol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?26/7/26743?source=related_link\">",
"      Tramadol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_5_30806="NASH liver biopsy";
var content_f30_5_30806=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F59170&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F59170&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nonalcoholic steatohepatitis liver biopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 255px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Liver biopsy showing steatosis, hepatocyte balloon degeneration, mixed acute and chronic inflammation, and pericellular fibrosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30806=[""].join("\n");
var outline_f30_5_30806=null;
var title_f30_5_30807="Pathogenesis of alcoholic liver disease";
var content_f30_5_30807=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis of alcoholic liver disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/5/30807/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/5/30807/contributors\">",
"     Scott L Friedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/5/30807/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/5/30807/contributors\">",
"     Bruce A Runyon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/5/30807/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/5/30807/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/5/30807/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of liver disease associated with alcohol ingestion is incompletely understood. What is known is that some patients who chronically abuse alcohol develop liver disease, primarily because the liver metabolizes the majority of ingested ethanol. Furthermore, the metabolism of ethanol is required for hepatic injury to occur, although variations in ethanol metabolism do not completely explain the variable susceptibility to alcoholic liver disease.",
"   </p>",
"   <p>",
"    This topic review will focus on three issues related to the development of alcoholic liver disease:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The basic aspects of alcohol metabolism",
"     </li>",
"     <li>",
"      The mechanisms that may be responsible for the development of hepatic disease",
"     </li>",
"     <li>",
"      The factors that determine the frequency with which alcohol abuse leads to liver disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The different pathologic types of alcoholic liver disease are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/42/21162?source=see_link\">",
"     \"Clinical manifestations and diagnosis of alcoholic fatty liver disease and alcoholic cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ALCOHOL METABOLISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ethanol is metabolized via several pathways, each of which can contribute to toxicity. The primary hepatic pathway generates acetaldehyde and reduced nicotinamide adenine dinucleotide (NAD) (",
"    <a class=\"graphic graphic_figure graphicRef61009 \" href=\"mobipreview.htm?25/5/25693\">",
"     figure 1",
"    </a>",
"    ). In addition, accessory inducible microsomal pathways may be responsible for the generation of toxic metabolites from several drugs, while a possible role for gastric ethanol metabolism remains controversial.",
"   </p>",
"   <p>",
"    Ethanol is metabolized first in the liver to acetaldehyde; this process occurs in the hepatocyte cytosol via a reaction catalyzed by the enzyme alcohol dehydrogenase (ADH) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/1\">",
"     1",
"    </a>",
"    ]. There are multiple forms of the dimeric ADH molecule, each comprised of different combinations of subunits encoded by separate gene loci [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/2\">",
"     2",
"    </a>",
"    ]. Polymorphisms of ADH do not predict the susceptibility to alcoholic liver disease but could explain variations in blood alcohol levels among individuals ingesting the same amount of ethanol.",
"   </p>",
"   <p>",
"    The acetaldehyde that is generated is subsequently metabolized to acetate, a process that occurs in the mitochondria and is catalyzed by a different enzyme, acetaldehyde dehydrogenase (ALDH). This enzyme, like ADH, has multiple isoforms with differing activities. Genetic variability in ALDH accounts for the well described flushing reaction among 75 percent of Asians who drink alcohol; this reaction resembles the response to alcohol in patients taking",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/17/5397?source=see_link\">",
"     disulfiram",
"    </a>",
"    (Antabuse).",
"   </p>",
"   <p>",
"    The flushing reaction in Asians is due to relative deficiency of ALDH2 isozyme, which results in the accumulation of acetaldehyde [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/3\">",
"     3",
"    </a>",
"    ]. Although acetaldehyde may be a potential accelerant to liver injury, this risk is generally offset by an aversion to further alcohol intake induced by flushing. As an example, the rate of alcoholism among Chinese subjects with this genotype is much lower than in other Chinese subjects; however, a separate reduced genetic risk of alcoholism in this subpopulation cannot be excluded [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     GASTRIC METABOLISM OF ALCOHOL",
"    </span>",
"    &nbsp;&mdash;&nbsp;The stomach has sufficient ADH activity to metabolize a significant amount of ingested alcohol. A study in 1990 aroused great interest by demonstrating that the metabolism of ingested ethanol in the stomach by gastric ADH was lower in women than men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/5\">",
"     5",
"    </a>",
"    ]. This was associated with increased levels of ethanol reaching the liver via the portal vein in women. This observation provides a potential explanation for why women seem to have an increased risk of liver injury, compared to men, for a given amount of chronic ethanol consumption. Infection with Helicobacter pylori and gastritis are other factors that can reduce the activity of gastric ADH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS OF ALCOHOLIC LIVER INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The strongest evidence for alcohol as a cause of liver disease comes from epidemiologic data, not biochemical or clinical studies. As an example, a marked reduction in the number of liver-related deaths was documented in the period after prohibition began in 1916 in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/7\">",
"     7",
"    </a>",
"    ]. Other data suggest that risk of alcoholic liver disease is related to the amount and duration of alcohol abuse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ALCOHOLIC STEATOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several factors contribute to the development of alcoholic fatty liver including reduced oxidation of hepatic fatty acids and increased lipogenesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/9\">",
"     9",
"    </a>",
"    ]. The altered redox state in the liver induced by alcohol impairs beta-oxidation and tricarboxylic acid cycle activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/10\">",
"     10",
"    </a>",
"    ]. Chronic ethanol consumption also increases expression of key lipogenic enzyme regulators, such as sterol regulatory element binding proteins (SREBPs) and SREBP-1 target genes, such as fatty acid synthase, acetyl-coenzyme A carboxylase, and steroyl-CoA desaturase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     ALCOHOLIC STEATOHEPATITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Not all patients with steatosis develop steatohepatitis. Several factors may contribute to the development of steatohepatitis including cytokines, oxidative stress, and toxic metabolic products of alcohol.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Cytokines and inflammation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Neutrophil infiltration and activation",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the most characteristic pathologic hallmarks of alcoholic hepatitis is infiltration of neutrophils, which are generally absent from other forms of inflammatory liver disease, generally in association with an increase in the peripheral neutrophil count [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/42/21162?source=see_link\">",
"     \"Clinical manifestations and diagnosis of alcoholic fatty liver disease and alcoholic cirrhosis\"",
"    </a>",
"    .) This observation has spawned a vigorous effort to determine if neutrophil infiltration with release of reactive oxygen species and proteases is at least in part responsible for the hepatic disease. Most attention has focused on characterization of mediators which stimulate chemotaxis, and which might direct migration of neutrophils into regions of alcohol metabolism. At least two compounds may be potentially relevant in this regard: interleukin-8 (IL-8) and a lipid metabolite of arachidonic acid.",
"   </p>",
"   <p>",
"    IL-8 is a member of the chemokine family, and a known neutrophil chemoattractant. Three studies have documented elevated plasma IL-8 levels in patients with alcoholic hepatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. The plasma IL-8 levels correlated with the severity of hepatic injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/12\">",
"     12",
"    </a>",
"    ] and IL-8 has been identified immunohistochemically in the liver in alcoholic patients. Whether IL-8 is produced locally in the liver and is required for injury to occur are unproven.",
"   </p>",
"   <p>",
"    Another neutrophil chemoattractant is an arachidonic acid metabolite related to leukotriene B4 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/15\">",
"     15",
"    </a>",
"    ]. The compound is released by cultured hepatocytes when incubated with ethanol, and requires ethanol metabolism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/15\">",
"     15",
"    </a>",
"    ]. Its generation probably results from free radical attack on membranes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/16\">",
"     16",
"    </a>",
"    ]. One source of these reactive oxygen species may be non-ADH pathways of ethanol oxidation, such as the MEOS. It is of interest that human but not rat neutrophils respond to the compound, which parallels the observation that rats are relatively resistant to ethanol and do not develop an alcoholic hepatitis-like lesion when fed comparable doses of ethanol as human alcoholics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Endotoxin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated levels of endotoxin (lipopolysaccharide [LPS]) have been detected in the blood of alcoholics and in animal models exposed to alcohol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/17\">",
"     17",
"    </a>",
"    ]. Endotoxin interacts with LPS-binding protein and binds to CD14, a receptor on the surface of Kupffer cells (liver macrophages). CD14 interacts with toll-like receptor type 4 (TLR4), which is involved in cytokine activation. It has been hypothesized that the increased levels of LPS contribute to the development of alcoholic liver disease by stimulating inflammatory cytokines. In support of this hypothesis are experiments in mice in which the LPS-binding protein, CD14 receptor, or TLR4 have been knocked out; all of these models are less likely to develop hepatic injury than wild-type controls when challenged with alcohol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/18-20\">",
"     18-20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On the other hand, contradictory data have also been published. One experimental model demonstrated that ethanol-fed animals given infusions of LPS developed increased expression of LPS binding protein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/21\">",
"     21",
"    </a>",
"    ]. While both pro- and anti-inflammatory cytokines responses were observed, the animals did not develop the net pro-inflammatory cytokine responses observed after acute LPS challenge [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/21\">",
"     21",
"    </a>",
"    ]. This suggests that alcoholics might develop tolerance to the chronic exposure to LPS and that LPS exposure may not be a central process in the development of alcoholic liver disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Injurious cytokines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have documented increased levels of the proinflammatory cytokines tumor necrosis factor and interleukin-6 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/12,22\">",
"     12,22",
"    </a>",
"    ]. These factors have been implicated in the hemodynamic alterations found in patients with cirrhosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/1/21527?source=see_link\">",
"     \"Pathogenesis of ascites in patients with cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Inflammatory cytokines also correlate with disease severity and histologic findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/23\">",
"     23",
"    </a>",
"    ]. While their role in alcohol-induced liver injury is unproven, evidence is mounting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/24\">",
"     24",
"    </a>",
"    ]. In one report, the hepatic inflammation and necrosis observed in ethanol-fed rats were significantly decreased by the administration of neutralizing antibodies to tumor necrosis factor-alpha (TNFa), suggesting a role for this cytokine in the pathogenesis of alcohol-induced liver injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/25\">",
"     25",
"    </a>",
"    ]. In another study, mice lacking the TNF receptor 1 gene (but not the TNF receptor 2 gene) were protected from the development of liver disease following ethanol ingestion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/26\">",
"     26",
"    </a>",
"    ]. A related molecule, TRAIL (tumor necrosis factor-related apoptosis-inducing ligand), may also contribute to the pathogenesis of steatosis and liver injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     COX-2 enzyme",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to TNFa, a role has emerged for cyclooxygenase 2 (COX-2). This enzyme, which produces prostaglandins, is elevated in experimental alcoholic liver injury, raising the possibility that inhibitors may have a therapeutic benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/28\">",
"     28",
"    </a>",
"    ]. Ethanol-fed rats show increased expression by Kupffer cells of cyclooxygenase 2 mRNA, a key enzyme regulating the production of thromboxanes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Furthermore, thromboxane inhibitors attenuate some of the pathologic changes in these animals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/30\">",
"     30",
"    </a>",
"    ]. It is uncertain whether this approach will be clinically useful. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/30/33258?source=see_link\">",
"     \"Pathogenesis of hepatic fibrosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Dietary fat",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammation may also be influenced by dietary fat. As an example, saturated fat is capable of down-regulating liver injury in experimental alcohol feeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Oxidative stress",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oxidative stress, damage to cells by reactive oxygen species, remains a major factor in alcoholic liver injury and fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. Diversion of ethanol to minor pathways of oxidation in heavy drinkers may be a critical determinant of liver injury because these pathways are more likely to generate injurious reactive oxygen intermediates than ADH. The main sources of reactive oxygen species are the mitochondria and CYP2E1 in hepatocytes and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in activated Kuppfer cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chronic alcohol consumption leads to the induction of microsomes (intracellular membrane compartments, such as smooth endoplasmic reticulum) due to spillover from the ADH pathway. The microsomal pathway has been referred to as the microsomal enzyme oxidation system (MEOS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/34\">",
"     34",
"    </a>",
"    ]. Induction of specific components of the MEOS, the membrane associated enzyme, cytochrome CYP2E1 has been documented in alcoholics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/35\">",
"     35",
"    </a>",
"    ] and contributes to the generation of oxidative stress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Polymorphisms of CYP2E1 correlate with differences in susceptibility to alcoholic liver disease, although a definitive role for polymorphisms in accounting for variable susceptibility to alcohol susceptibility remains uncertain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/38\">",
"     38",
"    </a>",
"    ]. Both ADH and CYP2E1 are more concentrated in the centrizonal region of the hepatic lobule, the area in which alcoholic liver injury is most prominent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/42/21162?source=see_link\">",
"     \"Clinical manifestations and diagnosis of alcoholic fatty liver disease and alcoholic cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chronic alcohol ingestion also leads to increased inducible nitric oxide synthase (iNOS) levels, which increase nitric oxide production [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/39\">",
"     39",
"    </a>",
"    ]. Nitric oxide reacts with reactive oxygen species to produce toxic compounds within the liver [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/10\">",
"     10",
"    </a>",
"    ]. One reactive species (superoxide) is produced by NADPH oxidase from Kuppfer cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Antigenic adduct formation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acetaldehyde and hydroxyethyl radicals are both derived from the oxidation of ethanol; they bind covalently to proteins, thereby forming adducts that are antigenic. Acetaldehyde, for example, is a highly reactive molecule that can bind avidly to the epsilon amino group of internal lysine residues and the alpha amino N-terminal amino acids of proteins, creating acetaldehyde-protein adducts via a Schiff base mechanism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/40\">",
"     40",
"    </a>",
"    ]. A number of potential intracellular protein targets have been proposed, including tubulin (a cytoskeletal protein) and collagen, a major component of the hepatic extracellular matrix. There are at least two potentially important consequences of adduct formation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adducts could form with intracellular proteins that are critical to cellular function, leading to dysfunction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Acetaldehyde protein adducts may serve as neoantigens, provoking both cell-mediated and humoral immune responses to attack cells bearing these compounds [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/42\">",
"       42",
"      </a>",
"      ]. This possibility could explain the large number of immunologic features long recognized in many patients with alcoholic liver injury [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/43\">",
"       43",
"      </a>",
"      ]. Several studies, for example, have identified antibodies in the serum of alcoholics which are reactive to acetaldehyde adducts; however, this observation does not easily explain how the antibodies might attack an intracellular protein. In addition, acetaldehyde-protein adducts have also been detected in patients with nonalcoholic liver disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hydroxyethyl radical adducts also may play an important role in the pathogenesis of alcohol-induced liver injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/44\">",
"     44",
"    </a>",
"    ]. In one report, animals given ethanol in vivo generated hydroxyethyl adducts on the external surface of hepatocytes that were recognized by antihydroxyethyl radical adduct antibodies that were present in the sera of cirrhotic patients. In the presence of monocytes, this antigen-antibody complex was able to trigger a cell-mediated cytotoxic reaction that killed the hepatocytes.",
"   </p>",
"   <p>",
"    The available data cannot determine if adducts have a pathogenic role or are simply an epiphenomenon of alcohol ingestion. Nevertheless, the last study is suggestive of a potentially important mechanism whereby alcohol can induce liver injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Immunologic",
"    </span>",
"    &nbsp;&mdash;&nbsp;The innate immune system is increasingly implicated in the liver's response to alcohol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/45\">",
"     45",
"    </a>",
"    ]. As an example, dendritic cell function may be altered in alcoholic liver disease, an effect that could impair the cell-mediated response to chronic hepatitis C virus infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/46\">",
"     46",
"    </a>",
"    ]. Altered dendritic function may also lead to increased release of proinflammatory cytokines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/47\">",
"     47",
"    </a>",
"    ]. Another study identified reduced expression of a glucocorticoid-induced leucine zipper protein, GILZ, which amplifies macrophage responses and sensitivity to lipopolysaccharide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     MECHANISM OF FIBROGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Great progress has been made in the past several years in identifying the cellular sources of extracellular matrix (ECM), or scar protein in alcoholic liver injury and in elucidating mechanisms of fibrogenesis. The ECM in fibrotic liver is comprised of several groups of molecules which together gradually form an insoluble scar, remarkably similar to the scar of cutaneous wounds. These components include \"interstitial\" collagens (types I and III), glycoproteins such as laminin and fibronectin, and proteoglycans such as dermatan and chondroitin sulfate. The composition of the hepatic scar is similar in all forms of fibrosing liver injury, supporting the concept that the fundamental response of the liver to injury is similar whether due to alcohol, drugs, viral infection, or metabolic abnormality (such as hemochromatosis).",
"   </p>",
"   <p>",
"    The hepatic stellate cell (also known as Ito cell or lipocyte) is the principal source of the ECM in hepatic fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/49\">",
"     49",
"    </a>",
"    ]. In normal liver, stellate cells are perisinusoidal cells distributed throughout the liver that are important for storing the bulk of hepatic vitamin A. With liver injury, these cells undergo a characteristic \"activation\" in which they lose vitamin A, proliferate, and become fibrogenic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/49\">",
"     49",
"    </a>",
"    ]. Stellate cell activation has been documented in both experimental alcoholic injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/50\">",
"     50",
"    </a>",
"    ] and human alcoholic fibrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Development of methods to isolate stellate cells from rat and human liver has greatly advanced our ability to study these cells and understand how they become activated in vivo. In particular, the release of cytokines from neighboring cells (paracrine activation) and alterations in the surrounding cellular microenvironment contribute to activation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/49,52\">",
"     49,52",
"    </a>",
"    ]. The major cytokines involved in this process include platelet-derived growth factor (PDGF), transforming growth factor-1, and endothelin-1.",
"   </p>",
"   <p>",
"    Mediators unique to alcoholic liver injury may also have a role. Acetaldehyde, a metabolite of alcohol, has minor fibrogenic activity towards cultured stellate cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/53\">",
"     53",
"    </a>",
"    ], but is unlikely to be a significant stimulant in vivo. Alcohol itself has no effect. However, increasing evidence supports a role for lipid aldehydes, which are unstable products of the interaction between reactive oxygen intermediates and cellular proteins. Free radicals responsible for this action could be a product of ethanol oxidation by the non-ADH microsomal enzyme oxidation system. Two lipid aldehydes in particular, 4-hydroxynonenal and malondialdehyde, are increased in experimental models of alcohol feeding to rodents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/54-57\">",
"     54-57",
"    </a>",
"    ], and may have fibrogenic activity. In addition, there may be other less stable intermediates, which act locally to activate stellate cells and stimulate matrix production. As methods for generating and measuring these unstable compounds improve, more information is likely to emerge about their pathogenic role. A more detailed review of hepatic fibrosis appears elsewhere [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30807/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/30/33258?source=see_link\">",
"     \"Pathogenesis of hepatic fibrosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pathogenesis of liver disease associated with alcohol ingestion is incompletely understood. What is known is that some patients who chronically abuse alcohol develop liver disease, primarily because the liver metabolizes the majority of ingested ethanol. Furthermore, the metabolism of ethanol is required for hepatic injury to occur, although variations in ethanol metabolism do not completely explain the variable susceptibility to alcoholic liver disease.",
"     </li>",
"     <li>",
"      Ethanol is metabolized via several pathways, each of which can contribute to toxicity. The primary hepatic pathway generates acetaldehyde and reduced nicotinamide adenine dinucleotide (NAD) (",
"      <a class=\"graphic graphic_figure graphicRef61009 \" href=\"mobipreview.htm?25/5/25693\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Alcohol metabolism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several factors contribute to the development of alcoholic fatty liver including reduced oxidation of hepatic fatty acids and increased lipogenesis. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Alcoholic steatosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Not all patients with steatosis develop steatohepatitis. Several factors may contribute to the development of steatohepatitis including cytokines, oxidative stress, and toxic metabolic products of alcohol. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Alcoholic steatohepatitis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H387279074\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The author and UpToDate would like to thank Dr. Jenny Sauk, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/1\">",
"      Kaplowitz N, Than TA, Shinohara M, Ji C. Endoplasmic reticulum stress and liver injury. Semin Liver Dis 2007; 27:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/2\">",
"      Lieber CS. Biochemical factors in alcoholic liver disease. Semin Liver Dis 1993; 13:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/3\">",
"      Bosron WF, Ehrig T, Li TK. Genetic factors in alcohol metabolism and alcoholism. Semin Liver Dis 1993; 13:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/4\">",
"      Enomoto N, Takase S, Yasuhara M, Takada A. Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. Alcohol Clin Exp Res 1991; 15:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/5\">",
"      Frezza M, di Padova C, Pozzato G, et al. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 1990; 322:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/6\">",
"      Thuluvath P, Wojno KJ, Yardley JH, Mezey E. Effects of Helicobacter pylori infection and gastritis on gastric alcohol dehydrogenase activity. Alcohol Clin Exp Res 1994; 18:795.",
"     </a>",
"    </li>",
"    <li>",
"     Zakim, D, Boyer, TD, Montgomery, C. Alcoholic liver disease. In: Hepatology. Textbook of Liver Disease, Saunders, Philadelphia 1990. p. 821.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/8\">",
"      Lelbach WK. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann N Y Acad Sci 1975; 252:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/9\">",
"      Zakim D, Alexander D, Sleisenger MH. The effect of ethanol on hepatic secretion of triglycerides into plasma. J Clin Invest 1965; 44:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/10\">",
"      Adachi M, Brenner DA. Clinical syndromes of alcoholic liver disease. Dig Dis 2005; 23:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/11\">",
"      You M, Fischer M, Deeg MA, Crabb DW. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 2002; 277:29342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/12\">",
"      Sheron N, Bird G, Koskinas J, et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993; 18:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/13\">",
"      Hill DB, Marsano LS, McClain CJ. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology 1993; 18:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/14\">",
"      Masumoto T, Onji M, Horiike N, Ohta Y. Assay of serum interleukin 8 levels in patients with alcoholic hepatitis. Alcohol Alcohol Suppl 1993; 1A:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/15\">",
"      Roll FJ, Perez HD, Serhan CN. Characterization of a novel arachidonic acid-derived neutrophil chemoattractant. Biochem Biophys Res Commun 1992; 186:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/16\">",
"      Roll FJ, Alexander MA, Cua D, et al. Metabolism of ethanol by rat hepatocytes results in generation of a lipid chemotactic factor: studies using a cell-free system and role of oxygen-derived free radicals. Arch Biochem Biophys 1991; 287:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/17\">",
"      Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 1987; 4:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/18\">",
"      Uesugi T, Froh M, Arteel GE, et al. Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J Immunol 2002; 168:2963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/19\">",
"      Yin M, Bradford BU, Wheeler MD, et al. Reduced early alcohol-induced liver injury in CD14-deficient mice. J Immunol 2001; 166:4737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/20\">",
"      Uesugi T, Froh M, Arteel GE, et al. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 2001; 34:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/21\">",
"      J&auml;rvel&auml;inen HA, Fang C, Ingelman-Sundberg M, Lindros KO. Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and proinflammatory and anti-inflammatory cytokines. Hepatology 1999; 29:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/22\">",
"      McClain C, Hill D, Schmidt J, Diehl AM. Cytokines and alcoholic liver disease. Semin Liver Dis 1993; 13:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/23\">",
"      Colmenero J, Bataller R, Sancho-Bru P, et al. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology 2007; 132:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/24\">",
"      McClain C, Barve S, Joshi-Barve S, et al. Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease. Alcohol Clin Exp Res 2005; 29:180S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/25\">",
"      Iimuro Y, Gallucci RM, Luster MI, et al. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997; 26:1530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/26\">",
"      Yin M, Wheeler MD, Kono H, et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999; 117:942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/27\">",
"      Mundt B, Wirth T, Zender L, et al. Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Gut 2005; 54:1590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/28\">",
"      Nanji AA, Zakim D, Rahemtulla A, et al. Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology 1997; 26:1538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/29\">",
"      Nanji AA, Miao L, Thomas P, et al. Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology 1997; 112:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/30\">",
"      Nanji AA, Khwaja S, Rahemtulla A, et al. Thromboxane inhibitors attenuate pathological changes in alcoholic liver disease in the rat. Gastroenterology 1997; 112:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/31\">",
"      Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 2001; 35:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/32\">",
"      Sampey BP, Stewart BJ, Petersen DR. Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase-1/2 activity via 4-hydroxynonenal. J Biol Chem 2007; 282:1925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/33\">",
"      Sastre J, Serviddio G, Pereda J, et al. Mitochondrial function in liver disease. Front Biosci 2007; 12:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/34\">",
"      Lieber CS, DeCarli LM. Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science 1968; 162:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/35\">",
"      Tsutsumi M, Lasker JM, Takahashi T, Lieber CS. In vivo induction of hepatic P4502E1 by ethanol: role of increased enzyme synthesis. Arch Biochem Biophys 1993; 304:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/36\">",
"      Zima T, Kalousov&aacute; M. Oxidative stress and signal transduction pathways in alcoholic liver disease. Alcohol Clin Exp Res 2005; 29:110S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/37\">",
"      Dryden GW Jr, Deaciuc I, Arteel G, McClain CJ. Clinical implications of oxidative stress and antioxidant therapy. Curr Gastroenterol Rep 2005; 7:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/38\">",
"      Tsutsumi M, Takada A, Wang JS. Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology 1994; 107:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/39\">",
"      Yuan GJ, Zhou XR, Gong ZJ, et al. Expression and activity of inducible nitric oxide synthase and endothelial nitric oxide synthase correlate with ethanol-induced liver injury. World J Gastroenterol 2006; 12:2375.",
"     </a>",
"    </li>",
"    <li>",
"     Tuma DJ, Sorrell MF. The role of acetaldehyde adducts in liver injury. In: Alcoholic Liver Disease, Hall P (Ed), Edward Arnold Press, London 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/41\">",
"      Niemel&auml; O, Parkkila S, Yl&auml;-Herttuala S, et al. Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation. Lab Invest 1994; 70:537.",
"     </a>",
"    </li>",
"    <li>",
"     Bird GL, MacSween RN. Pathogenesis of alcoholic liver disease: Immune mechanisms. In: Alcoholic Liver Disease, Hall P (Ed), Edward Arnold Press, London 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/43\">",
"      Holstege A, Bedossa P, Poynard T, et al. Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: localization and association with progression of liver fibrosis. Hepatology 1994; 19:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/44\">",
"      Clot P, Parola M, Bellomo G, et al. Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol. Gastroenterology 1997; 113:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/45\">",
"      Szabo G, Mandrekar P, Dolganiuc A. Innate immune response and hepatic inflammation. Semin Liver Dis 2007; 27:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/46\">",
"      Aloman C, Gehring S, Wintermeyer P, et al. Chronic ethanol consumption impairs cellular immune responses against HCV NS5 protein due to dendritic cell dysfunction. Gastroenterology 2007; 132:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/47\">",
"      Laso FJ, Vaquero JM, Almeida J, et al. Chronic alcohol consumption is associated with changes in the distribution, immunophenotype, and the inflammatory cytokine secretion profile of circulating dendritic cells. Alcohol Clin Exp Res 2007; 31:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/48\">",
"      Hamdi H, Bigorgne A, Naveau S, et al. Glucocorticoid-induced leucine zipper: A key protein in the sensitization of monocytes to lipopolysaccharide in alcoholic hepatitis. Hepatology 2007; 46:1986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/49\">",
"      Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134:1655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/50\">",
"      Tsukamoto H, Gaal K, French SW. Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: status report. Hepatology 1990; 12:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/51\">",
"      Okanoue T, Burbige EJ, French SW. The role of the Ito cell in perivenular and intralobular fibrosis in alcoholic hepatitis. Arch Pathol Lab Med 1983; 107:459.",
"     </a>",
"    </li>",
"    <li>",
"     Maher JJ, Friedman SL. Pathogenesis of hepatic fibrosis. In: Alcoholic Liver Disease, Hall P (Ed), Edward Arnold Press, London 1995. p.71.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/53\">",
"      Casini A, Cunningham M, Rojkind M, Lieber CS. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 1991; 13:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/54\">",
"      Kamimura S, Gaal K, Britton RS, et al. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. Hepatology 1992; 16:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/55\">",
"      Kawase T, Kato S, Lieber CS. Lipid peroxidation and antioxidant defense systems in rat liver after chronic ethanol feeding. Hepatology 1989; 10:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/56\">",
"      Albano E. Alcohol, oxidative stress and free radical damage. Proc Nutr Soc 2006; 65:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30807/abstract/57\">",
"      Purohit V, Brenner DA. Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium. Hepatology 2006; 43:872.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3613 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-40244E071D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30807=[""].join("\n");
var outline_f30_5_30807=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ALCOHOL METABOLISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      GASTRIC METABOLISM OF ALCOHOL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS OF ALCOHOLIC LIVER INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ALCOHOLIC STEATOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      ALCOHOLIC STEATOHEPATITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Cytokines and inflammation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Neutrophil infiltration and activation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Endotoxin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Injurious cytokines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - COX-2 enzyme",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Dietary fat",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Oxidative stress",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Antigenic adduct formation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Immunologic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      MECHANISM OF FIBROGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H387279074\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/3613\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/3613|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/5/25693\" title=\"figure 1\">",
"      Pathways of ethanol metabolism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/42/21162?source=related_link\">",
"      Clinical manifestations and diagnosis of alcoholic fatty liver disease and alcoholic cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/1/21527?source=related_link\">",
"      Pathogenesis of ascites in patients with cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/30/33258?source=related_link\">",
"      Pathogenesis of hepatic fibrosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_5_30808="Overview of fears and specific phobias in children";
var content_f30_5_30808=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of fears and specific phobias in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/5/30808/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/5/30808/contributors\">",
"     Marilyn Augustyn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/5/30808/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/5/30808/contributors\">",
"     David Brent, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/5/30808/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/5/30808/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/5/30808/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;All children have fears at some point in their lives [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/1\">",
"     1",
"    </a>",
"    ]. Most of these are transient and resolve spontaneously. Children whose fears interfere with daily functioning may warrant additional evaluation for specific phobia.",
"   </p>",
"   <p>",
"    An overview of fears and specific phobias in children will be presented here. Phobic disorders in adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/15/10488?source=see_link\">",
"     \"Agoraphobia in adults: Epidemiology, clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/24/22921?source=see_link\">",
"     \"Specific phobia in adults: Epidemiology, clinical manifestations, course and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/39/9849?source=see_link\">",
"     \"Acute procedure anxiety in adults: Epidemiology and clinical presentation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/32/11782?source=see_link\">",
"     \"Acute procedure anxiety in adults: Course, screening, assessment, and differential diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Fear",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fear is an unpleasant emotion with cognitive, behavioral, and physiologic components [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/2\">",
"     2",
"    </a>",
"    ]. It occurs in response to a consciously recognized source of danger, either real or imaginary. Normal fears are age specific (eg, fear of the dark, fear of separation) and have intensity that is proportional to the perceived threat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Significant fears may reflect an accurate assessment of a truly harmful situation or a displacement of emotion from another environmental stressor (eg, physical or sexual abuse). (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Phobia",
"    </span>",
"    &nbsp;&mdash;&nbsp;A phobia is a persistent and compulsive dread of and preoccupation with the feared object or situation. The child may realize that the dread is out of proportion to the danger, but remains unable to feel reassured and avoids the object or situation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/2,5-7\">",
"     2,5-7",
"    </a>",
"    ]. Phobias interfere with the child's functioning in a way that fears do not.",
"   </p>",
"   <p>",
"    The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) classifies phobias as anxiety disorders and describes three types: specific phobia (formerly called simple phobia), social phobia, and agoraphobia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/6\">",
"     6",
"    </a>",
"    ]. Each of these phobic disorders may occur in children and adolescents.",
"   </p>",
"   <p>",
"    The discussion in this topic review is limited to specific phobias. The DSM-IV-TR criteria for specific phobia are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef81555 \" href=\"mobipreview.htm?38/54/39787\">",
"     table 1",
"    </a>",
"    ). In individuals younger than 18 years, phobic symptoms must be present for at least six months to meet criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The differentiation of fears from phobias in young children can be difficult [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/5\">",
"     5",
"    </a>",
"    ]. Young children may not be able to provide the relevant information regarding the degree of anxiety or functional impairment, nor may they view the fears as excessive or unreasonable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/2,8\">",
"     2,8",
"    </a>",
"    ]. Approximately 20 percent of children have fears that meet the criteria for specific phobias (",
"    <a class=\"graphic graphic_table graphicRef81555 \" href=\"mobipreview.htm?38/54/39787\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;All children have fears at some point in their lives [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/1\">",
"     1",
"    </a>",
"    ]. Children between two and six years usually have approximately four fears, whereas children between 6 and 12 years have an average of seven. The number of fears typically peaks at age 11 years and then decreases with age.",
"   </p>",
"   <p>",
"    Fearfulness tends to run in families, although the relative contributions of genetics and shared environment are not clear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/4,11,12\">",
"     4,11,12",
"    </a>",
"    ]. Studies of identical twins suggest a genetic predisposition to fearfulness in some children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/4,12\">",
"     4,12",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Etiology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Girls report fears more often than boys, possibly because it is more socially acceptable for them to do so [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/1,5,13,14\">",
"     1,5,13,14",
"    </a>",
"    ]. Parents may underreport their child's fears. In one review, mothers underreported their child's fears by up to 40 percent.",
"   </p>",
"   <p>",
"    A number of surveys, using different methodologies, have evaluated the prevalence of specific phobias during childhood and adolescence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/15-19\">",
"     15-19",
"    </a>",
"    ]. The prevalence ranges from 3 to 9 percent, with an average of approximately 5 percent across studies from community samples and 15 percent across studies from clinic-referred samples [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/2\">",
"     2",
"    </a>",
"    ]. These findings should be interpreted with caution because of the difficulty in differentiating fears from phobias in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/2,5\">",
"     2,5",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Terminology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Specific phobia of the natural environment type (eg, heights, storms, weather) usually has onset in childhood, whereas situational-type specific phobia (eg, planes, elevators, enclosed places) usually has onset in the mid-20s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/6\">",
"     6",
"    </a>",
"    ]. The blood-injection-injury type of specific phobia tends to run in families and is often characterized by a vasovagal response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of childhood fears and phobias is not well understood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/2,5\">",
"     2,5",
"    </a>",
"    ]. A number of factors may be at play; these include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/2,20-24\">",
"     2,20-24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Genetic predisposition",
"     </li>",
"     <li>",
"      Temperamental tendencies (eg, the tendency to react with distress and withdrawal when confronted with unfamiliar people or situations)",
"     </li>",
"     <li>",
"      Direct conditioning through traumatic or frightening experiences (eg, dog bite)",
"     </li>",
"     <li>",
"      Vicarious conditioning through observation of phobic reaction in others",
"     </li>",
"     <li>",
"      Negative information transmission (eg, through reading, hearing about, or seeing frightening events in person or in the media)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The final three factors are known as Rachman's pathways to fear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. However, some individuals have fears that are not associated with one of these pathways [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. One explanation for the existence of these non-associative fears is that they pertain to stimuli that threatened the survival of human ancestors and, therefore, reflect innate, spontaneous reactions to evolutionary cues [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Developmental factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The objects of the child's fear change with the sophistication of his or her cognitive development [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/13,29\">",
"     13,29",
"    </a>",
"    ]. The primitive reflexes reflect two basic fears (some argue that \"fear\" may not be the appropriate term) present at birth: fear of falling (loss of support) and of loud noises [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/7\">",
"     7",
"    </a>",
"    ]. Subsequent fears reflect the child's increasing awareness of his or her world, the development of imagination (eg, fear of monsters and ghosts), and, finally, the ability to differentiate internal representations from objective reality (eg, realistic fears involving bodily injury) (",
"    <a class=\"graphic graphic_table graphicRef54750 \" href=\"mobipreview.htm?21/19/21819\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/13,30,31\">",
"     13,30,31",
"    </a>",
"    ]. Fear is intensified and expanded by exposure to danger in the real world. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Environmental factors'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    One study compared the fears of three-, five-, and seven-year-olds with those of adults who listened to stories about two protagonists of different ages (infant and child or child and grown-up) who encounter an entity that looks like a real (eg, a snake) or an imaginary (eg, a ghost) fear-inducing creature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/32\">",
"     32",
"    </a>",
"    ]. Subjects were then asked to predict and explain each protagonist's intensity of fear. Results showed significant age-related increases in knowledge that infants and adults would experience less intense fears than young children and that people's fears are causally linked to their cognitive mental states. Across age, stories involving imaginary beings elicited more frequent mental explanations for fear than stories about real creatures. The authors hypothesize that this relates to the developing awareness of the mind in young children, which helps to mediate between real and imaginary situations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Environmental factors",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Triggers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The onset of fears often relates to a triggering event. As an example, a young child may become fearful of dogs after a startling experience with a large dog. The (perhaps) innate human fear of large animals is intensified because the child's cognitive level does not permit an explanation of the event that is nonthreatening.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Familial factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observation of the behavior of other family members in response to certain stimuli or situations also may influence the development of fears [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/5,8,14,33\">",
"     5,8,14,33",
"    </a>",
"    ]. A predisposition to fearfulness can be reinforced by parents' or grandparents' fearful behavior and validation that certain things (eg, dogs, thunderstorms) are dangerous [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/5,34\">",
"     5,34",
"    </a>",
"    ]. On the other hand, family members who do not share the child's fears are likely to provide reassurance and help the child to overcome his or her fear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Support strategies'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The potential link between parental psychopathology and childhood fears has been explored in observational studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/35\">",
"     35",
"    </a>",
"    ]. In a study of 318 children of parents with lifetime Major Depressive Disorder (MDD), anxiety disorder, MDD+anxiety disorder, or neither, specific fears were significantly elevated in offspring of parents with MDD+anxiety disorder relative to the other groups. The authors concluded that elevated rates of specific fears in offspring of parents with MDD+anxiety disorder may be a function of more severe parental psychopathology, increased genetic loading, or unmeasured environmental influences. In a large longitudinal study of twins, which followed three distinct fear factors, situational, animal, and",
"    <span class=\"nowrap\">",
"     blood/injury,",
"    </span>",
"    researchers found that over time, fears change and that genetic effects on fear are developmentally dynamic from middle childhood to young adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/24\">",
"     24",
"    </a>",
"    ]. As children age, familial-environmental influences on fears decline in importance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Childhood fears and phobias present in a variety of ways. Physiologic symptoms of fear include tachycardia, shaking, difficulty breathing, dizziness, or lightheadedness. Young children may cry, have a tantrum, or cling to their parent or caregiver [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/2,6,36\">",
"     2,6,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Older children develop somatic complaints or try to avoid the fear-provoking object or situation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/8,36\">",
"     8,36",
"    </a>",
"    ]. They may not tell their parents about the fear, especially if they suspect that the fear is not warranted. In such cases, it may be the avoidant behavior rather than the fear that brings the child to medical attention (eg, the constipation or encopresis that results from fear and avoidance of toilets, the fatigue that results from fear of the dark) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/5\">",
"     5",
"    </a>",
"    ]. Children with specific phobias may develop rituals or compulsions (repetitive, purposeful, intentional behaviors) in response to their fears [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Criteria for referral'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The severity of avoidance",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    anticipatory anxiety often is the major factor in presenting for medical attention, particularly if it interferes with daily activities and social relationships [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/5,36\">",
"     5,36",
"    </a>",
"    ]. Transient fears are seldom brought to the attention of the pediatric health care provider [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/5\">",
"     5",
"    </a>",
"    ]. However, routinely asking about fears provides an opportunity to determine whether the quantity and intensity of the fears are within the normal realm and to discuss parental responses that can help to relieve or reinforce the child's anxiety. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Diagnosis'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H17\">",
"     'Parental education'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H18\">",
"     'Support strategies'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of a child who presents with symptoms of fear centers on determining whether the symptoms represent a simple fear, a specific phobia (",
"    <a class=\"graphic graphic_table graphicRef81555 \" href=\"mobipreview.htm?38/54/39787\">",
"     table 1",
"    </a>",
"    ), a response to significant environmental pathology (eg, a violent neighborhood or household, a bully at school), or a displacement of emotion from another source of stress (eg, physical or sexual abuse). Management of the latter two may require referral for \"trauma mastery\" or other forms of mental health services.",
"   </p>",
"   <p>",
"    In addition to taking a thorough psychosocial history to explore the possibilities of environmental pathology and sources of stress, important questions related to the fear include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Does the fear interrupt the child's daily schedule more than three times per day?",
"     </li>",
"     <li>",
"      Can anyone recall a specific trigger for the fear?",
"     </li>",
"     <li>",
"      How do the parents usually respond to the fear?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It can be helpful to obtain information from multiple informants (eg, the child, parents,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    teachers) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/8\">",
"     8",
"    </a>",
"    ]. Children may be more aware of their inner distress, whereas parents",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    teachers may better appreciate the impact on family or school functioning.",
"   </p>",
"   <p>",
"    Several questionnaires have been adapted to obtain this information in a methodic manner [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/38\">",
"     38",
"    </a>",
"    ]. One tool, the Fear Survey Schedule for Infants-Preschoolers (FSSIP), was compared to routine questioning. The FSSIP demonstrated high internal consistency, low to moderate test-retest correlations over an average of six months, and good convergent and discriminant validity.",
"   </p>",
"   <p>",
"    The physical examination of the child who presents with symptoms of fear is usually normal. However, it is important to exclude medical conditions that may have similar physiologic manifestations (eg, hypoglycemia, hyperthyroidism, pheochromocytoma) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/8,36\">",
"     8,36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/0/8201?source=see_link\">",
"     \"Approach to hypoglycemia in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/22/21865?source=see_link\">",
"     \"Acquired hypothyroidism in childhood and adolescence\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/14/38121?source=see_link\">",
"     \"Pheochromocytoma in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fears and phobias are diagnosed clinically. Several clinical features distinguish fears from phobias; the most important is the degree to which the fear interferes with daily activities:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fears do not affect daily activities, play, or development; phobias do.",
"     </li>",
"     <li>",
"      Fears respond to reassurance; phobias do not.",
"     </li>",
"     <li>",
"      Fears have a plausible event as a cause; phobias do not.",
"     </li>",
"     <li>",
"      Fears can be extinguished with distraction; phobias cannot.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of fears and specific phobias includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Appropriate response to environmental pathology (eg, a bully at school).",
"     </li>",
"     <li>",
"      Displacement of emotion from another source of stress (eg, physical or sexual abuse, ill family member).",
"     </li>",
"     <li>",
"      Other phobic and anxiety disorders (eg, social phobia disorder, agoraphobia, separation anxiety disorder, generalized anxiety disorder, obsessive compulsive disorder, panic disorder, or posttraumatic stress disorder).",
"      <br/>",
"      <br/>",
"      In considering these conditions, the child's developmental status must be taken into consideration. As an example, fear of separation, which usually begins in the latter half of the first year, is normal in infants and young children, but usually resolves by six years of age.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The above conditions can usually be distinguished from fears and specific phobias by taking a thorough psychosocial history. The degree of pervasiveness and emergence of symptoms with respect to various situations helps to differentiate between the various anxiety disorders:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Specific phobia is provoked by exposure to a specific object or situation and often leads to avoidant behavior (",
"      <a class=\"graphic graphic_table graphicRef81555 \" href=\"mobipreview.htm?38/54/39787\">",
"       table 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Social phobia is characterized by fear and avoidance of circumscribed social situations (eg, eating or speaking in public) or more commonly, all social situations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Agoraphobia is characterized by fear of being in a place or situation from which escape might be difficult or embarrassing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Separation anxiety disorder is characterized by anxiety about actual or anticipated separation from attachment figures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Generalized anxiety disorder (GAD) is characterized by excessive or unrealistic anxiety or worry for six months or longer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/6\">",
"       6",
"      </a>",
"      ]. Although phobias are often present in GAD, the fears are less focused and more global (eg, the future) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Obsessive compulsive disorder (OCD) is characterized by obsessions (which cause marked anxiety or distress)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      compulsions (which serve to neutralize anxiety) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Panic disorders involve an acute and intense physiologic activation characterized by palpitations and profound discomfort [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Posttraumatic stress disorder (PTSD) and acute stress disorder develop after experiencing a traumatic event. Characteristic features include reexperiencing the trauma, symptoms of increased arousal, and avoidance of stimuli associated with the trauma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/6\">",
"       6",
"      </a>",
"      ]. PTSD symptoms must be present for more than one month to meet DSM-IV-TR criteria. In acute stress disorder, the symptoms occur within four weeks of the traumatic event and persist for a minimum of two days and a maximum of four weeks.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management strategies depend upon whether the child has a simple fear, a debilitating phobia, or an appropriate response to environmental pathology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Simple fears",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of management of simple fears is to help the child learn positive ways to cope with and transcend the fear. Learning to explore, modify, minimize, and overcome targeted fears is an important mission of childhood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The management of simple fears has not been evaluated in controlled trials. Nonetheless, we suggest that simple fears be managed through reassurance, education, experience,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    exploration through play (eg, games involving monsters, scary animals, or ghosts) since these strategies appear to help children to overcome their fears [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Parental reassurance, including a pledge to protect the child as necessary, is effective therapy for most simple fears [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/5\">",
"     5",
"    </a>",
"    ]. Younger children are usually comforted by reassurance that is simple and direct; older children need more detailed explanation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some fears, such as fear of the dark, are likely to be self-limited. In such cases, providing a night light and teaching the child simple cognitive self-control strategies may be all that is necessary [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/36,40\">",
"     36,40",
"    </a>",
"    ]. Cognitive self-control strategies include relaxation, visualizing a pleasant scene, and positive self-statement (eg, \"I can take care of myself in the dark\") [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Parental education",
"    </span>",
"    &nbsp;&mdash;&nbsp;Education of parents and caregivers is an important component of treatment of childhood fears. Parents should understand that simple fears are normal and do not necessarily represent a problem in the child or the environment. All children, even those in the most secure and loving of homes, develop fears as a result of their limited ability to understand the complexity of the world.",
"   </p>",
"   <p>",
"    The child's fears should be acknowledged, but not exaggerated or belittled. Parents should respect the child's inclination to withdraw from the stimulus, but the anxiety should not be reinforced or exacerbated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/5,36\">",
"     5,36",
"    </a>",
"    ]. Fears can be exacerbated in the following ways:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      By using them as a threat (eg, \"The doctor is going to give you a shot if you're not good\")",
"     </li>",
"     <li>",
"      By humiliating the child (eg, \"Only babies are afraid of bugs\")",
"     </li>",
"     <li>",
"      By indifference to the child's distress",
"     </li>",
"     <li>",
"      By unrealistic expectations to master the fear",
"     </li>",
"     <li>",
"      By overprotecting the child or permitting him or her to avoid the feared stimulus; this confirms the child's hypothesis that the stimulus is to be feared; in addition, the relief of symptoms at being allowed to avoid the stimulus reinforces the avoidance behavior [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Support strategies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Support should be provided to the child as he or she develops an increased mastery of the feared object. Mastery of fear may involve initial avoidance of the fearful stimulus, detailed discussions about the fear with attempts to correct cognitive misconceptions, and finally, a gradual introduction to the feared stimulus with much family support.",
"   </p>",
"   <p>",
"    Learning to cope with a fear often involves breaking it down to individual components: physical, cognitive, and behavioral. Techniques that are helpful in addressing the various components of fear include imagination, information, observation, and exposure. For fears in young children that cannot be reasoned away, it may be necessary to resort to comprehensible and concrete actions (eg, \"monster-proofing\" the bedroom).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Criteria for referral",
"    </span>",
"    &nbsp;&mdash;&nbsp;Referral to a mental health professional for management of specific phobia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    evaluation and management of other anxiety disorders may be warranted in the following circumstances [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/36\">",
"     36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fears significantly hamper the child's activities of daily living",
"     </li>",
"     <li>",
"      Fears begin to generalize from the object or situation of origin",
"     </li>",
"     <li>",
"      Development of avoidance behavior or compulsions",
"     </li>",
"     <li>",
"      The initial treatment does not result in relief of symptoms",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Threatening environment",
"    </span>",
"    &nbsp;&mdash;&nbsp;For children whose fear represents an appropriate response to environmental pathology, it is important for the parents to point out what is being done to protect the child and to involve the child in identifying additional steps that could be taken [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/5,42\">",
"     5,42",
"    </a>",
"    ]. Involvement of social services and or mental health professionals may be warranted to help engage the child in \"trauma mastery.\" (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/23/31097?source=see_link&amp;anchor=H19#H19\">",
"     \"Childhood exposure to intimate partner violence\", section on 'Intervention'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Specific phobias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with mild specific phobias can be managed in the same way as children with simple fears. Children with more severe or debilitating phobias should be referred to a mental health professional. Specialty treatment of specific phobias may involve behavioral or cognitive-behavioral therapy (CBT) or psychopharmacology. Behavioral approaches may include the use of behavioral contracts, modeling, and desensitization, often in combination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/25,36,43\">",
"     25,36,43",
"    </a>",
"    ]. We suggest that children with specific phobias be referred to a qualified mental health clinician for cognitive behavioral therapy and desensitization.",
"   </p>",
"   <p>",
"    Most specific phobias in children and adolescents respond to treatment with relief of major symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/36\">",
"     36",
"    </a>",
"    ]. However, the treatment modalities have not been well studied in controlled trials. This makes it difficult to attribute resolution to treatment because symptoms also resolve in children who are not treated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A systematic review of CBT for anxiety disorders (not limited to specific phobia) in children found evidence to support the efficacy of cognitive-behavioral interventions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/41\">",
"     41",
"    </a>",
"    ]. Compared to wait-list, inactive, and active control children, those who received CBT experienced medium to large treatment effects for symptom reduction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Behavioral contracts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contracts use specific contingencies to positively reinforce the desired behavior toward the stimulus (eg, the child earns a sticker for permitting the dog that he or she is afraid of to come closer). The use of contracts helps to ensure that the treatment guidelines are followed by the patient and family outside of the office setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Modeling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Modeling involves direct observation of the desired behavior as demonstrated by the clinician or family members [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/25,36\">",
"     25,36",
"    </a>",
"    ]. The individual demonstrating the desired behavior initially shows a level of fear comparable to the child's, but overcomes the fear to perform the desired behavior (eg, not avoiding the feared stimulus).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Desensitization",
"    </span>",
"    &nbsp;&mdash;&nbsp;In systematic desensitization, the child learns to cope with anxiety through relaxation strategies (eg, visual imagery, muscle relaxation, controlled breathing) and cognitive approaches that reinforce the realization that the feared situation is safe. During therapy, while in a relaxed state, the patient is exposed to a gradual hierarchy of stimuli that eventually approach the feared object or situation. The exposure is performed through imagery or in vivo. In vivo exposure appears to be more effective than computerized images [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/45,46\">",
"     45,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In adults with specific phobias, in vivo exposure is an effective technique; approximately 70 to 90 percent of adults with specific phobia respond to in vivo exposure, often with only one session of prolonged exposure to the phobic stimulus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Single-session in vivo exposure in children and adolescents with specific phobia has been demonstrated to be as effective as systematic desensitization, at least for some phobias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/45,46,49\">",
"     45,46,49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications generally have a minimal role in the treatment of specific phobia if there is no psychiatric comorbidity. A possible exception is the case of a circumscribed, anticipated exposure to a feared object or situation that is unavoidable (eg, thunderstorms, fear of flying) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/50\">",
"     50",
"    </a>",
"    ]. In these circumstances, medications are used only to treat the symptoms of the phobia, not the actual phobia, and are temporizing at best. They should be prescribed as part of the overall treatment plan by the mental health clinician who is treating the phobia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most fears are transient and resolve with time. However, fears that are not confronted can persist.",
"   </p>",
"   <p>",
"    Long-term follow-up studies of children with specific phobias are limited; those that exist suggest a positive long-term outcome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/44,51\">",
"     44,51",
"    </a>",
"    ]. In one series of 10 untreated patients younger than 20 years, symptoms improved in six and resolved in four within five years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/44\">",
"     44",
"    </a>",
"    ]. However, adults seeking treatment for phobias and other anxiety disorders often report having had similar symptoms during childhood or adolescence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/29,36\">",
"     29,36",
"    </a>",
"    ]. As a general rule, the more severe the anxiety disorder and the greater the impairment in functioning, the more likely it is to persist [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30808/abstract/52,53\">",
"     52,53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A list of resources for parents and children is provided in the table (",
"    <a class=\"graphic graphic_table graphicRef65443 \" href=\"mobipreview.htm?43/28/44492\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fear is an unpleasant emotion with cognitive, behavioral, and physiologic components that occurs in response to real or imaginary danger. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Fear'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A specific phobia is a persistent and compulsive dread of and preoccupation with the feared object or situation that interferes with the child's ability to function normally (",
"      <a class=\"graphic graphic_table graphicRef81555 \" href=\"mobipreview.htm?38/54/39787\">",
"       table 1",
"      </a>",
"      ). The dread is out of proportion to the danger and results in avoidance of the feared stimulus. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Phobia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Childhood fears and phobias present in a variety of ways. Physiologic symptoms of fear include tachycardia, shaking, difficulty breathing, dizziness, or lightheadedness. Young children may cry, have a tantrum, or cling to their parent or caregiver. Older children may develop somatic complaints or try to avoid the fear-provoking object or situation. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The goals of the evaluation of a child who presents with symptoms or fear are to differentiate simple fear from other conditions with similar symptoms and to determine the presence of behaviors that may be reinforcing the fear. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Evaluation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Differential diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Parental education'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several clinical features distinguish fears from phobias; the most important of these is the degree to which the fear interferes with daily activities. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that simple fears be managed through reassurance, education, experience,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      exploration through play (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Simple fears'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Referral to a mental health professional may be warranted if the fear affects the child's activities of daily living, if the fear begins to generalize from the object or situation of origin, if the child develops avoidance behavior or compulsions, or if the initial treatment does not result in relief of symptoms. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Criteria for referral'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with specific phobias should be referred to a mental health professional for treatment. Specialty treatment of specific phobias may involve behavioral or cognitive-behavioral therapy (eg, behavioral contracts, modeling, desensitization) or psychopharmacology. We suggest that children with specific phobias be treated with cognitive behavioral therapy and desensitization by a qualified mental health clinician (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Specific phobias'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/1\">",
"      Ollendick TH, Yang B, King NJ, et al. Fears in American, Australian, Chinese, and Nigerian children and adolescents: a cross-cultural study. J Child Psychol Psychiatry 1996; 37:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/2\">",
"      Ollendick, T. Fears and phobias in children: Phenomenology, epidemiology, and aetiology. Child Adolesc Ment Health 2002; 7:98.",
"     </a>",
"    </li>",
"    <li>",
"     Bennet Johnson, S, Melamed, BG. The assessment and treatment of children's fears. In: Advances in child psychology, Lahey, BB, Kazdin, A (Eds), Plenum Press, New York 1979. p.107.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/4\">",
"      Kashani JH, Orvaschel H. A community study of anxiety in children and adolescents. Am J Psychiatry 1990; 147:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/5\">",
"      Schowalter JE. Fears and phobias. Pediatr Rev 1994; 15:384.",
"     </a>",
"    </li>",
"    <li>",
"     Anxiety Disorders. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR&reg;). American Psychiatric Association, Washington, DC 2000. p.429.",
"    </li>",
"    <li>",
"     Anxious symptoms. In: The Classification of Child and Adolescent Mental Diagnoses in Primary Care. Diagnostic and Statistical Manual for Primary Care (DSM-PC) Child and Adolescent Version. Wolraich, ML (Ed). American Academy of Pediatrics, Elk Grove Village, IL 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/8\">",
"      Connolly SD, Bernstein GA, Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007; 46:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/9\">",
"      Muris P, Merckelbach H. How serious are common childhood fears? II. The parent's point of view. Behav Res Ther 2000; 38:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/10\">",
"      Muris P, Merckelbach H, Mayer B, Prins E. How serious are common childhood fears? Behav Res Ther 2000; 38:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/11\">",
"      Fyer AJ, Mannuzza S, Gallops MS, et al. Familial transmission of simple phobias and fears. A preliminary report. Arch Gen Psychiatry 1990; 47:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/12\">",
"      Stevenson J, Batten N, Cherner M. Fears and fearfulness in children and adolescents: a genetic analysis of twin data. J Child Psychol Psychiatry 1992; 33:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/13\">",
"      Bauer DH. An exploratory study of developmental changes in children's fears. J Child Psychol Psychiatry 1976; 17:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/14\">",
"      Meltzer H, Vostanis P, Dogra N, et al. Children's specific fears. Child Care Health Dev 2009; 35:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/15\">",
"      Anderson JC, Williams S, McGee R, Silva PA. DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population. Arch Gen Psychiatry 1987; 44:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/16\">",
"      McGee R, Feehan M, Williams S, et al. DSM-III disorders in a large sample of adolescents. J Am Acad Child Adolesc Psychiatry 1990; 29:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/17\">",
"      Bird HR, Canino G, Rubio-Stipec M, et al. Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico. The use of combined measures. Arch Gen Psychiatry 1988; 45:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/18\">",
"      Steinhausen HC, Metzke CW, Meier M, Kannenberg R. Prevalence of child and adolescent psychiatric disorders: the Z&uuml;rich Epidemiological Study. Acta Psychiatr Scand 1998; 98:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/19\">",
"      Essau CA, Conradt J, Petermann F. Frequency, comorbidity, and psychosocial impairment of specific phobia in adolescents. J Clin Child Psychol 2000; 29:221.",
"     </a>",
"    </li>",
"    <li>",
"     Brent, D, Rabinovich, H, Birmaher, B, Campo, J. Major psychiatric disorders in childhood and adolescence. In: Developmental Behavioral Pediatrics, 3rd ed, Levine, MD, Carey, WB, Crocker, AC (Eds), WB Saunders, Philadelphia 1999. p.632.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/21\">",
"      Muris P, Merckelbach H, de Jong P, Ollendick TH. The etiology of specific fears and phobias in children: a critique of the non-associative account. Behav Res Ther 2002; 40:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/22\">",
"      Rachman S. The passing of the two-stage theory of fear and avoidance: fresh possibilities. Behav Res Ther 1976; 14:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/23\">",
"      Rachman S. The conditioning theory of fear-acquisition: a critical examination. Behav Res Ther 1977; 15:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/24\">",
"      Kendler KS, Gardner CO, Annas P, et al. A longitudinal twin study of fears from middle childhood to early adulthood: evidence for a developmentally dynamic genome. Arch Gen Psychiatry 2008; 65:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/25\">",
"      Merckelbach H, Muris P, Schouten E. Pathways to fear in spider phobic children. Behav Res Ther 1996; 34:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/26\">",
"      King NJ, Eleonora G, Ollendick TH. Etiology of childhood phobias: current status of Rachman's three pathways theory. Behav Res Ther 1998; 36:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/27\">",
"      Menzies RG, Clarke JC. The etiology of childhood water phobia. Behav Res Ther 1993; 31:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/28\">",
"      McNally RJ, Steketee GS. The etiology and maintenance of severe animal phobias. Behav Res Ther 1985; 23:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/29\">",
"      Ferrari M. Fears and phobias in childhood: some clinical and developmental considerations. Child Psychiatry Hum Dev 1986; 17:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/30\">",
"      Gordon J, King NJ, Gullone E, et al. Treatment of children's nighttime fears: the need for a modern randomised controlled trial. Clin Psychol Rev 2007; 27:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/31\">",
"      King N, Ollendick TH, Tonge BJ. Children's nighttime fears. Clin Psychol Rev 1997; 17:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/32\">",
"      Sayfan L, Lagattuta KH. Grown-ups are not afraid of scary stuff, but kids are: young children's and adults' reasoning about children's, infants', and adults' fears. Child Dev 2008; 79:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/33\">",
"      Muris P, Steerneman P, Merckelbach H, Meesters C. The role of parental fearfulness and modeling in children's fear. Behav Res Ther 1996; 34:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/34\">",
"      Christophersen, ER, VanScoyoc, SM. Stormy weather. Advise parents on how to handle weather-related fears among children. AAP News 2006; 27:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/35\">",
"      Biel MG, Klein RG, Mannuzza S, et al. Does major depressive disorder in parents predict specific fears and phobias in offspring? Depress Anxiety 2008; 25:379.",
"     </a>",
"    </li>",
"    <li>",
"     Le Roux, P, McCann, CM. Phobias. In: Primary Pediatric Care, 4th ed. Hoekelman, RA (Ed), Mosby, St. Louis 2001. p.848.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/37\">",
"      Evans DW, Gray FL, Leckman JF. The rituals, fears and phobias of young children: insights from development, psychopathology and neurobiology. Child Psychiatry Hum Dev 1999; 29:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/38\">",
"      Warren SL, Ollendick TH, Simmens SJ. Reliability and validity of the Fear Survey Schedule for Infants-Preschoolers. Depress Anxiety 2008; 25:E205.",
"     </a>",
"    </li>",
"    <li>",
"     Levine, ML. Middle childhood. In: Developmental Behavioral Pediatrics, 3rd ed, Levine MD, Carey, WB, Crocker, AC (Eds), WB Saunders, Philadelphia 1999. p.51.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/40\">",
"      Ollendick TH, Hagopian LP, Huntzinger RM. Cognitive-behavior therapy with nighttime fearful children. J Behav Ther Exp Psychiatry 1991; 22:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/41\">",
"      Compton SN, March JS, Brent D, et al. Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry 2004; 43:930.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Fears and Phobias. In: Caring for Your School-Age Child Ages 5 to 12. The Complete and Authoritative Guide. Schor, EL (Ed), American Academy of Pediatrics, Elk Grove Vill, IL 1995. p.263.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/43\">",
"      Albano AM, Chorpita BF. Treatment of anxiety disorders of childhood. Psychiatr Clin North Am 1995; 18:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/44\">",
"      Agras WS, Chapin HN, Oliveau DC. The natural history of phobia. Course and prognosis. Arch Gen Psychiatry 1972; 26:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/45\">",
"      Muris P, Merckelbach H, Holdrinet I, Sijsenaar M. Treating phobic children: effects of EMDR versus exposure. J Consult Clin Psychol 1998; 66:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/46\">",
"      Muris P, Merckelbach H, Van Haaften H, Mayer B. Eye movement desensitisation and reprocessing versus exposure in vivo. A single-session crossover study of spider-phobic children. Br J Psychiatry 1997; 171:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/47\">",
"      Ost LG. One-session treatment for specific phobias. Behav Res Ther 1989; 27:1.",
"     </a>",
"    </li>",
"    <li>",
"     Marks, IM. Fears, Phobias and Rituals. Oxford University Press, New York 1987.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/49\">",
"      Ost LG, Svensson L, Hellstr&ouml;m K, Lindwall R. One-Session treatment of specific phobias in youths: a randomized clinical trial. J Consult Clin Psychol 2001; 69:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/50\">",
"      Balon R. Fluvoxamine for phobia of storms. Acta Psychiatr Scand 1999; 100:244.",
"     </a>",
"    </li>",
"    <li>",
"     Ollendick, TH, King, NJ, Yule, W (Eds). International handbook of phobic and anxiety disorders in children and adolescents, Plenum Press, New York 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/52\">",
"      Dadds MR, Spence SH, Holland DE, et al. Prevention and early intervention for anxiety disorders: a controlled trial. J Consult Clin Psychol 1997; 65:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30808/abstract/53\">",
"      Manassis K, Hood J. Individual and familial predictors of impairment in childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 1998; 37:428.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1226 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-340D2F8564-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30808=[""].join("\n");
var outline_f30_5_30808=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Fear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Phobia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Developmental factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Environmental factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Triggers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Familial factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Simple fears",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Parental education",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Support strategies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Criteria for referral",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Threatening environment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Specific phobias",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Behavioral contracts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Modeling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Desensitization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Medications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/1226\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/1226|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/54/39787\" title=\"table 1\">",
"      DSM-IV-TR criteria for specific phobia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/19/21819\" title=\"table 2\">",
"      Common fears in childhood and adolescence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?43/28/44492\" title=\"table 3\">",
"      Resources for families of children with fears",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/22/21865?source=related_link\">",
"      Acquired hypothyroidism in childhood and adolescence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/32/11782?source=related_link\">",
"      Acute procedure anxiety in adults: Course, screening, assessment, and differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/39/9849?source=related_link\">",
"      Acute procedure anxiety in adults: Epidemiology and clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/15/10488?source=related_link\">",
"      Agoraphobia in adults: Epidemiology, clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/0/8201?source=related_link\">",
"      Approach to hypoglycemia in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/23/31097?source=related_link\">",
"      Childhood exposure to intimate partner violence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/14/38121?source=related_link\">",
"      Pheochromocytoma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/24/22921?source=related_link\">",
"      Specific phobia in adults: Epidemiology, clinical manifestations, course and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_5_30809="Radiofrequency ablation for the treatment of lower extremity chronic venous disease";
var content_f30_5_30809=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Radiofrequency ablation for the treatment of lower extremity chronic venous disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/5/30809/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/5/30809/contributors\">",
"     Sherry Scovell, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/5/30809/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/5/30809/contributors\">",
"     John F Eidt, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/5/30809/contributors\">",
"     Joseph L Mills, Sr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/5/30809/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/5/30809/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/5/30809/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency ablation (RFA) is a minimally invasive percutaneous technique using thermal energy to ablate incompetent veins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. This device is used primarily to treat insufficiency of the axial veins (ie, great, small, or accessory saphenous veins) but intersaphenous veins or perforator veins can also be treated with specialized probes.",
"   </p>",
"   <p>",
"    Alternative approaches to treatment of chronic venous disease using laser and light therapy, endovenous laser, sclerotherapy, and open surgical management are discussed elsewhere.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/45/34521?source=see_link\">",
"       \"Overview and management of lower extremity chronic venous disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/40/17031?source=see_link\">",
"       \"Laser and light therapy of lower extremity telangiectasias, reticular veins and small varicose veins\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/12/13514?source=see_link\">",
"       \"Liquid and foam sclerotherapy techniques for the treatment of lower extremity veins\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/29/21977?source=see_link\">",
"       \"Open surgical techniques for lower extremity vein ablation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candidates for radiofrequency ablation are patients with persistent",
"    <span class=\"nowrap\">",
"     symptoms/signs",
"    </span>",
"    of venous disease after a minimum of three months of medical therapy plus documented reflux (ie, retrograde flow &gt;0.5 second duration) as a source of their symptoms. The vein to be treated is generally &gt;5mm which should easily accommodate the device. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/45/34521?source=see_link\">",
"     \"Overview and management of lower extremity chronic venous disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/41/32410?source=see_link\">",
"     \"Medical management of lower extremity chronic venous disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency ablation should not be performed in patients who have signs of acute",
"    <span class=\"nowrap\">",
"     thrombosis/phlebitis,",
"    </span>",
"    due to the increased risk of deep venous thrombosis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    thromboembolism. Pregnant patients should defer until after delivery.",
"   </p>",
"   <p>",
"    Diabetes and peripheral arterial occlusive disease are relative contraindications because these conditions are associated with an increased risk of non-healing wounds. When arterial and venous diseases are identified, the arterial disease needs to be addressed first. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/31/30201?source=see_link\">",
"     \"Clinical features, diagnosis, and natural history of lower extremity peripheral artery disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Very large veins are a relative contraindication. Vein diameter greater than 15 mm may have a higher risk of Type I failure (ie, non closure); however, successful closure has been reported for veins as large as 24 mm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/3\">",
"     3",
"    </a>",
"    ]. Alterations in technique can be used to manage larger veins. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Procedure'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H31\">",
"     'Anatomic failure'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Venous anatomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major superficial veins of the lower extremity include the great and small saphenous veins (",
"    <a class=\"graphic graphic_figure graphicRef55019 graphicRef52340 \" href=\"mobipreview.htm?5/25/5527\">",
"     figure 1A-B",
"    </a>",
"    ). These and the saphenous accessory veins are collectively referred to as axial veins. The great saphenous vein joins the common femoral vein at the confluence of the superficial inguinal veins via the saphenofemoral junction (SFJ). The small saphenous vein has more variable anatomy, especially with respect to the location of the saphenopopliteal junction (SPJ) (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/29/11735?source=see_link&amp;anchor=H22#H22\">",
"     \"Classification of lower extremity chronic venous disorders\", section on 'Superficial venous system (As)'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The deep veins of the lower extremity are contained within the deep muscle compartments bounded by the muscle fascia (",
"    <a class=\"graphic graphic_figure graphicRef75219 \" href=\"mobipreview.htm?42/56/43906\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/29/11735?source=see_link&amp;anchor=H24#H24\">",
"     \"Classification of lower extremity chronic venous disorders\", section on 'Deep venous system (Ad)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Perforating veins traverse the muscular fascia to connect superficial veins with the deep veins. They are located anteriorly, posteriorly, laterally and medially in both the thigh and calf.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Saphenous nerve",
"    </span>",
"    &nbsp;&mdash;&nbsp;The saphenous nerve is a terminal branch, and the largest cutaneous branch, of the femoral nerve and provides sensory innervation to the medial aspect of the lower leg. It passes through the adductor canal, after which it becomes superficial and closely related to the saphenous vein. The saphenous nerve is most vulnerable to injury in the distal calf, where it actually adheres to the saphenous vein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Sural nerve",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sural nerve is a cutaneous nerve coursing along the small saphenous vein and traversing posterior to the lateral malleolus toward the fifth toe (",
"    <a class=\"graphic graphic_figure graphicRef62917 \" href=\"mobipreview.htm?0/17/272\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     RADIOFREQUENCY DEVICES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency ablation devices generate a high frequency alternating current (in the radio range of frequencies, 300 kHz to 1 MHz) that is transmitted through an electrode. The resultant energy heats the vein wall adjacent the probe to a prespecified temperature which alters the protein structure of the vein, effecting its closure.",
"   </p>",
"   <p>",
"    The original radiofrequency ablation catheter (VNUS Closure&trade;) was available in two sizes and introduced through a 6F or 8F sheath. The tip heated to 85 or 90 degrees Celsius and then the catheter pulled back slowly (1 to 2 mm per second), maintaining a constant temperature to effect closure of the vein. This catheter is no longer available.",
"   </p>",
"   <p>",
"    The subsequent catheter design (ClosureFast&trade;) is available for an 8F delivery system, and heats to 120 degrees Celsius. Energy is delivered over 20 second intervals to a 7 cm catheter segment. The catheter is withdrawn in a series of 7 cm steps with the number of steps depending upon the length of the vein being treated; pullback times are generally faster than with the original catheter.",
"   </p>",
"   <p>",
"    Catheters designed to treat perforator veins (ClosureRFS&reg;, rFITT&reg;) are shorter and have smaller catheter diameters. They are introduced either through a sheath or by direct puncture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PREOPERATIVE ISSUES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     Aspirin",
"    </a>",
"    , antiplatelet agents and nonsteroidal anti-inflammatory medications are sometimes discontinued to limit postoperative bruising. However, when these medications are continued, the success of the vein closure is not affected.",
"   </p>",
"   <p>",
"    The need for medical anticoagulation is not a contraindication to endovenous ablation. Endovenous ablation can be undertaken safely with successful outcomes in anticoagulated patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     Warfarin",
"    </a>",
"    may be temporarily discontinued or bridging anticoagulation initiated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/50/35626?source=see_link\">",
"     \"Management of anticoagulation before and after elective surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An anxiolytic (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    10 mg orally) can be given approximately one hour prior to the procedure to help the patient relax.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Antibiotic prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prophylactic antibiotics are generally given even though these are clean cases. The radiofrequency procedure is often combined with vein excisions which may have a higher risk for surgical site infection due to frequent hematoma formation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=see_link\">",
"     \"Overview of control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     DVT prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;DVT prophylaxis is generally not administered prior to radiofrequency ablation.",
"   </p>",
"   <p>",
"    Patients with a known thrombophilia, or at high risk for venous thromboembolism, are anticoagulated perioperatively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=see_link&amp;anchor=H8#H8\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\", section on 'High risk patients'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/12/23752?source=see_link&amp;anchor=H13#H13\">",
"     \"Management of inherited thrombophilia\", section on 'Surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Perioperative anticoagulation (eg, low molecular weight",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    ) in patients at high risk for deep venous",
"    <span class=\"nowrap\">",
"     thrombosis/thromboembolism,",
"    </span>",
"    or other medical reasons does not appear to affect the success of vein closure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/7-9\">",
"     7-9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Patient counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decision to offer radiofrequency ablation depends upon symptoms, response to medical therapy, extent of lower extremity venous disease, and patient expectations. The patient is made aware that:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unforeseen anatomic issues may result in technical failure (ie, the inability to perform an endovenous procedure), in which case the patient may need to be rescheduled for a repeat of alternate procedure.",
"     </li>",
"     <li>",
"      In spite of successful technical application of the endovenous device, non-closure of the vein (primary failure) or late secondary failure (ie, vein recanalization) may occur and may be more common in larger diameter veins. In these cases, radiofrequency ablation may be repeated or an alternate procedure can be performed. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Anatomic failure'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Associated varicosities that have not been excised or sclerosed should become less noticeable, but may not completely disappear. Supplemental phlebectomy or sclerotherapy may be required to achieve the desired cosmetic result [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/10-12\">",
"       10-12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Whether to perform simultaneous versus delayed phlebectomy of any residual veins should be discussed, as well as the pros and cons of each approach.",
"     </li>",
"     <li>",
"      Other risks of the procedure include bleeding, infection, phlebitis, deep venous thrombosis, and cutaneous nerve injury leading to numbness or paresthesias.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Alternatives to radiofrequency ablation include no therapy, sclerotherapy, laser ablation, or surgical removal of refluxing superficial veins. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/41/32410?source=see_link\">",
"     \"Medical management of lower extremity chronic venous disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/12/13514?source=see_link\">",
"     \"Liquid and foam sclerotherapy techniques for the treatment of lower extremity veins\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/34/30250?source=see_link\">",
"     \"Endovenous laser ablation for the treatment of lower extremity chronic venous disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/29/21977?source=see_link\">",
"     \"Open surgical techniques for lower extremity vein ablation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Compression stockings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients are prescribed Class II or higher compression stockings (eg, thigh-high or pantyhose), which they should obtain prior to the day of the scheduled procedure (",
"    <a class=\"graphic graphic_table graphicRef74574 \" href=\"mobipreview.htm?36/42/37547\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/41/32410?source=see_link\">",
"     \"Medical management of lower extremity chronic venous disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Follow-up duplex appointment",
"    </span>",
"    &nbsp;&mdash;&nbsp;A prescheduled appointment should be made for follow-up duplex examination two to three days following the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Vein mapping/marking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to the procedure, the veins to be ablated are evaluated and mapped (ie, marked with indelible ink) with duplex ultrasound to identify vein size and depth, confirm the presence of reflux, identify the presence of any large perforating veins or existing superficial or deep venous thrombosis, or any significant anatomic variations (eg, duplication, early entrance of the vein into the deep venous system) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     PROCEDURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency ablation can be performed in the office setting (appropriately equipped operative suite) or ambulatory surgery center under sterile conditions. Although some surgeons will perform bilateral saphenous ablation in a single session, it is our preference not to perform bilateral procedures due to increased postoperative pain and discomfort that might impair ambulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Follow-up care'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The procedure is typically performed with local anesthesia with or without oral or intravenous sedation, but general anesthesia may be appropriate depending on the nature of the procedure (ie, extensive concurrent phlebectomy) or patient",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    surgeon preference. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19817?source=see_link\">",
"     \"Overview of anesthesia and anesthetic choices\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Preparation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3107736\">",
"    <span class=\"h3\">",
"     Equipment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Duplex ultrasound machine",
"     </li>",
"     <li>",
"      Endovenous device: Check the machine for proper functioning; calibrate if necessary.",
"     </li>",
"     <li>",
"      Roller pump for tumescent anesthesia (eg, Klein pump)",
"     </li>",
"     <li>",
"      Table with Trendelenburg and reverse Trendelenburg positions",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3107753\">",
"    <span class=\"h3\">",
"     Medications",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Local anesthetic for puncture site: 1%",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"     </li>",
"     <li>",
"      Tumescent anesthetic: The tumescent anesthetic mixture (saline, epinephrine,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      ) should be ordered from the pharmacy in advance and mixed just prior to the procedure. Cold saline solution may be an alternative for patients with allergy to local anesthesia or at risk for toxicity (eg, impaired liver function) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Heparinized saline: 100 Units per mL dilution.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3107760\">",
"    <span class=\"h3\">",
"     Materials",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Preparation materials: skin prep, sterile gloves",
"     </li>",
"     <li>",
"      Draping materials: sterile drape, bag for foot",
"     </li>",
"     <li>",
"      Roller pump tubing",
"     </li>",
"     <li>",
"      Echogenic 21 gauge micropuncture needle",
"     </li>",
"     <li>",
"      5 mL syringe with 16 to 20 gauge needle to draw up anesthetic, 27 to 30 gauge needle to inject",
"     </li>",
"     <li>",
"      Micropuncture sheath kit: micropuncture wire (0.018\"), 5F",
"      <span class=\"nowrap\">",
"       dilator/sheath,",
"      </span>",
"      sheath flushed with heparinized saline",
"     </li>",
"     <li>",
"      Catheter sheath kit: 0.035 J-wire,",
"      <span class=\"nowrap\">",
"       dilator/sheath",
"      </span>",
"      (6F or 8F) flushed with heparinized saline",
"     </li>",
"     <li>",
"      Assorted guidewires: 0.035\" Bentson wire, Glidewire&reg; (0.018, 0.025)",
"     </li>",
"     <li>",
"      Wound dressing: adhesive strips or Steri-strips&trade;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     General technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency ablation is performed according to the manufacturer's recommendation. The general technique is described below.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Prepare and position the patient",
"      </strong>",
"      &ndash; Following sterile preparation of the lower extremity, the patient is placed in reverse Trendelenburg position to facilitate visualization of the veins for sheath placement.",
"     </li>",
"     <li>",
"      <strong>",
"       Place the device sheath",
"      </strong>",
"      &ndash; With ultrasound guidance, an echogenic micropuncture needle is used to access the chosen vein and the micropuncture",
"      <span class=\"nowrap\">",
"       dilator/sheath",
"      </span>",
"      placed with the Seldinger technique. The inner dilator of the micropuncture sheath is removed, a J-wire is placed through the micropuncture sheath and checked with ultrasound; the micropuncture sheath is then removed. The 6 or 8 F",
"      <span class=\"nowrap\">",
"       dilator/sheath",
"      </span>",
"      is placed over the 0.035\" wire, the wire and inner dilator removed, and the 6 or 8 F sheath flushed with heparinized saline. On occasion, the vein is unable to be accessed percutaneously. Pressure is applied to the puncture site to control bleeding as needed. Percutaneous access can be reattempted more proximally or a small cutdown performed and the sheath introduced directly into the vein.",
"     </li>",
"     <li>",
"      <strong>",
"       Position the catheter",
"      </strong>",
"      &ndash; The ultrasound probe is placed at the proximal extent of the planned ablation (eg, saphenofemoral or saphenopopliteal junction) and the radiofrequency catheter is placed through the sheath. The catheter often advances through the vein with ease; however, excessive tortuosity or the presence of large perforator veins may necessitate the need for a guidewire. A long, floppy wire (eg, glidewire 0.025\") is placed through the sheath and advanced to the proximal vein under ultrasound guidance. Once the position of the wire is confirmed, the catheter is passed over the guidewire and positioned in the proximal vein. The tip of the catheter is positioned at least 2 cm below the saphenofemoral or saphenopopliteal junction. For the great saphenous vein, the optimal closure level is below the origin of the superficial epigastric vein to preserve flow in the proximal great saphenous vein [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Instill tumescent anesthesia",
"      </strong>",
"      &ndash; With ultrasound visualization, the echogenic micropuncture needle is used to inject tumescent anesthesia into the tissue surrounding the vein. The tumescent anesthesia limits heat transfer to tissues beyond the vein, anesthetizes these tissues to decrease pain, and causes venoconstriction, which places the vein in close apposition to the ablation catheter.",
"     </li>",
"     <li>",
"      <strong>",
"       Ablate the vein",
"      </strong>",
"      &ndash; Once the tumescent is instilled, the patient is placed in Trendelenburg position to empty the veins. The position of the tip of the catheter is re-evaluated with ultrasound since the installation of tumescent tends to straighten the vein and push the tip cephalad. Vein ablation is carried out according to the manufacturer's specifications for the type of catheter chosen. The device is activated, transferring energy to the blood and vein wall, resulting in immediate intimal loss and subsequent thrombosis as the probe is withdrawn [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/18\">",
"       18",
"      </a>",
"      ]. Vein wall thickening, inflammatory change and, ultimately, fibrotic closure of the vein occur with time. Compression of the vein during the ablation procedure is commonly performed to maintain a correct level of electrical impedance.",
"     </li>",
"     <li>",
"      <strong>",
"       Perform completion ultrasound",
"      </strong>",
"      &ndash; A completion ultrasound is performed to evaluate the closure of the vein. Following radiofrequency ablation, the treated vein has thickened walls (ie, hyperechoic doughnut) with thrombus in the lumen of the vein and no identifiable venous flow. The junction of the treated vein with the deep venous system is also imaged to exclude the presence of deep venous thrombosis. The proximal vein at the junction should be compressible and hypoechoic and without the presence of any intraluminal debris which would appear hyperechoic.",
"     </li>",
"     <li>",
"      <strong>",
"       Perform supplemental procedures",
"      </strong>",
"      &ndash; Following successful closure of the targeted veins, the extremity is evaluated for any significant residual varicose veins, which can be managed with either phlebectomy or sclerotherapy depending upon size or operator preference. Large varicose veins and those located on the thigh are less likely to respond to elimination of reflux, and we prefer to manage these concurrently with the ablation procedure. For smaller veins, supplemental procedures may be delayed as many of these smaller veins will reduce in size over time. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/29/21977?source=see_link\">",
"       \"Open surgical techniques for lower extremity vein ablation\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/12/13514?source=see_link\">",
"       \"Liquid and foam sclerotherapy techniques for the treatment of lower extremity veins\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Specific anatomic considerations",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Great saphenous ablation",
"      </strong>",
"      &ndash; Great saphenous ablation is performed with the catheter tip positioned 2 cm below the saphenofemoral junction, ideally below the origin of the superficial epigastric vein. The sheath is typically placed above the knee to minimize the likelihood of injury to the saphenous nerve. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Nerve injury'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Small saphenous ablation",
"      </strong>",
"      &ndash; In small saphenous ablation, the catheter tip is positioned 2 cm distal to the saphenopopliteal junction. The sheath is placed at the lower border of the gastrocnemius muscle. Tumescent anesthesia is instilled, as with the great saphenous vein, and the procedure is performed with the patient in Trendelenburg position. Instillation of the tumescent is extremely important in small saphenous vein ablation because of the proximity of the vein to the sural nerve.",
"     </li>",
"     <li>",
"      <strong>",
"       Accessory saphenous ablation",
"      </strong>",
"      &ndash; Compared with the saphenous veins, the accessory veins have a shorter straight segment and the remainder is tortuous. The straight portion of the vein can be ablated with the radiofrequency device and the more tortuous segments subsequently managed with phlebectomy. Accessory saphenous ablation is performed in a manner similar to great saphenous ablation. The catheter tip is positioned 2 cm below the saphenofemoral junction. Adequate tumescent anesthesia is important since these veins can be more superficial.",
"     </li>",
"     <li>",
"      <strong>",
"       Perforator ablation",
"      </strong>",
"      &ndash; Incompetent perforator veins (IPVs) can also be occluded with radiofrequency (ie, TRans-Luminal Occlusion of Perforators [TRLOP]) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/19,20\">",
"       19,20",
"      </a>",
"      ]. Two general methods use either rigid or flexible catheters. The procedure is performed with ultrasound guidance. The perforator is accessed either directly or with the Seldinger technique. The catheter is positioned 5 to 10 mm above the muscular fascia to avoid application of heat to the deep veins. The tumescent is administered while the catheter is held in place. With the patient in Trendelenburg position, the ablation is performed according to the manufacturer's specifications for the chosen device. The catheter is removed and completion ultrasound performed.",
"     </li>",
"     <li>",
"      <strong>",
"       Intersaphenous vein ablation",
"      </strong>",
"      &ndash; Endovenous ablation of incompetent intersaphenous veins can also be performed with specialized radiofrequency probes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     FOLLOW-UP CARE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Pain management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extra strength",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    should suffice in the initial postoperative period if radiofrequency ablation is the only procedure performed. Nonsteroidal antiinflammatory agents can be added in patients who develop a significant phlebitic reaction. Extensive concurrent vein excision (ie, phlebectomy) may require stronger analgesics (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/0/35848?source=see_link\">",
"     codeine",
"    </a>",
"    ). An ice pack can also be applied to the affected areas for comfort.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Patient instructions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperatively, we instruct patients to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ambulate normally. Make an effort in the first postoperative day to walk every hour before bedtime and then daily for 15 to 30 minutes.",
"     </li>",
"     <li>",
"      Avoid prolonged standing and sitting; when seated, elevate the treated extremity.",
"     </li>",
"     <li>",
"      Avoid heavy lifting and exercise for two weeks.",
"     </li>",
"     <li>",
"      Resume normal job duties within three to four days; however, jobs requiring prolonged",
"      <span class=\"nowrap\">",
"       standing/heavy",
"      </span>",
"      lifting may require additional time off.",
"     </li>",
"     <li>",
"      Maintain the postoperative dressing and elastic",
"      <span class=\"nowrap\">",
"       bandages/stockings",
"      </span>",
"      until the postoperative duplex examination, which should occur within two to three days following the procedure.",
"     </li>",
"     <li>",
"      Reinforce any areas of bleeding that occur through the dressing, but call their physician if excessive bleeding occurs. This is more commonly associated with vein excisions performed at the same time as the endovenous ablation.",
"     </li>",
"     <li>",
"      Wear their compression",
"      <span class=\"nowrap\">",
"       stockings/bandages",
"      </span>",
"      continuously for the first 48 hours and then during the day for the next two weeks.",
"     </li>",
"     <li>",
"      Not to be alarmed at the development of a",
"      <span class=\"nowrap\">",
"       pulling/tugging",
"      </span>",
"      sensation along the course of the treated vein. This is due to the scarring of the vein, which adheres it to the surrounding tissues. Gentle stretching exercises may help.",
"     </li>",
"     <li>",
"      Call their physician if they notice numbness, tingling, coolness or discoloration of the toes of the treated extremity. The postoperative compression",
"      <span class=\"nowrap\">",
"       bandages/stockings",
"      </span>",
"      may be too tight and need to be removed.",
"     </li>",
"     <li>",
"      Call their physician promptly if they experience swelling or excessive pain not relieved with the prescribed pain medications because this may be a symptom of deep vein thrombosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Postoperative duplex ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;A follow-up duplex ultrasound is performed within two to three days of the procedure to evaluate the presence of deep venous thrombosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common duplex finding following great saphenous ablation in the groin is an open, competent, saphenofemoral junction with less than 5 cm of patent terminal greater saphenous vein segment and vein wall thickening and thrombus in the distal vein. Prograde flow is visualized from the saphenous tributaries into the proximal saphenous vein; saphenofemoral reflux is uncommon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/9,22\">",
"     9,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients identified to have deep venous thrombosis are treated accordingly. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'Deep venous thrombosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Thrombus may be identified at the",
"    <span class=\"nowrap\">",
"     saphenofemoral/saphenopopliteal",
"    </span>",
"    junction, extending up to, but not into, the deep vein. Repeat duplex examination is performed usually within a week to evaluate for any propagation.",
"   </p>",
"   <p>",
"    A classification system has been proposed to provide an accurate description of the level of proximal great saphenous thrombus for the purpose of guiding clinical therapy and further research [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/17\">",
"     17",
"    </a>",
"    ]. The classification scheme is as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Level &nbsp; I: Thrombus below the superficial epigastric vein",
"     </li>",
"     <li>",
"      Level &nbsp;II: Thrombus up to the origin of the superficial epigastric vein",
"     </li>",
"     <li>",
"      Level III: Thrombus up to but not into the common femoral vein",
"     </li>",
"     <li>",
"      Level IV: Thrombus bulging into the common femoral vein but adherent to the wall of the common femoral vein (ie, DVT)",
"     </li>",
"     <li>",
"      Level &nbsp;V: Thrombus extending into the common femoral vein but not occlusive (ie, DVT)",
"     </li>",
"     <li>",
"      Level VI: Occlusive thrombus of the common femoral vein (ie, DVT)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     LOCAL ADVERSE REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Significant pain is not typical following radiofrequency ablation even when vein excisions are concurrently performed. Vein rupture with ecchymosis or hematoma formation is uncommon. Skin burns, hyperpigmentation and telangiectatic matting are also infrequent with this technique (&lt;1 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications associated with radiofrequency ablation include superficial thrombophlebitis, cutaneous nerve injury and deep venous thrombosis. The development of AV fistula has been reported following perforator ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Superficial thrombophlebitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A mild superficial thrombophlebitis is anticipated along the course of the ablated vein, but retrograde extension into neighboring tributaries may cause pain and inflammation in regions which appear remote from the ablation procedure. Superficial thrombophlebitis is managed conservatively. More significant signs or symptoms of pain or edema warrant ultrasound examination to evaluate for the presence of proximal clot extension. The management of patients with duplex confirmed extension of thrombus up to but not into the deep venous system (Level I, II, III) following endovenous ablation is controversial. Patients have been managed with serial duplex examinations, anticoagulation or open surgical ligation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/23\">",
"     23",
"    </a>",
"    ]. We prefer serial duplex and repeat ultrasound within a week if thrombus is identified at the",
"    <span class=\"nowrap\">",
"     saphenofemoral/saphenopopliteal",
"    </span>",
"    junction, extending up to, but not into, the deep vein. The management of superficial thrombophlebitis is discussed elsewhere (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/25/43417?source=see_link&amp;anchor=H20#H20\">",
"     \"Superficial thrombophlebitis of the lower extremity\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Nerve injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sensory abnormalities are reported in zero to 22 percent of patients following ablation of the great saphenous vein and are usually transient. Small saphenous ablation may be associated with sural nerve paresthesias (",
"    <a class=\"graphic graphic_figure graphicRef62917 \" href=\"mobipreview.htm?0/17/272\">",
"     figure 3",
"    </a>",
"    ). Injury to the superficial peroneal nerve has also been reported, but is more likely related to concurrent vein excisions. Great saphenous nerve injury may be more likely when the endovenous sheath is placed below the level of the knee, due to the adherence of the saphenous nerve to the saphenous vein in the distal third of the calf [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H36\">",
"     'Clinical outcomes'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Deep venous thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deep vein thrombosis (DVT) and thromboembolism have been reported following radiofrequency ablation; however, at experienced centers, the risk is &lt;1 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/21,24,25\">",
"     21,24,25",
"    </a>",
"    ]. The majority of venous thrombosis following radiofrequency ablation appears to be related to extension of clot from thrombus induced in the ablated vein. Endovenous heat-induced thrombosis is a term (EHIT) which refers to this mechanism. Direct thermal injury to the deep veins can also occur due to catheter malposition.",
"   </p>",
"   <p>",
"    In one retrospective study, deep venous thrombosis was not significantly associated with patient demographics, ablation indication, type of anesthesia or use of adjunctive procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/25\">",
"     25",
"    </a>",
"    ]. However, a separate review of 500 patients found that great saphenous vein diameter &gt;8 mm at the level of the saphenofemoral junction, or a history of DVT increased the risk for thrombus extension into the femoral vein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients diagnosed with thrombus within the deep veins are anticoagulated (Level IV, V, VI) and a follow-up duplex ultrasound should be obtained within 7 to 10 days. In some cases of EHIT following great saphenous ablation, thrombus contraction occurs and thrombus is no longer apparent within the common femoral vein, at which point anticoagulation may be discontinued. Persistence of deep vein thrombus is managed according to standard protocols. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link&amp;anchor=H45#H45\">",
"     \"Treatment of lower extremity deep vein thrombosis\", section on 'VTE and a reversible or time-limited risk factor'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Technical complications",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Anatomic failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following saphenous ablation, duplex ultrasound can show procedural failure, yet some of these patients may still have clinical improvement that is maintained long-term. Anatomic failure is a useful term to distinguish these patients from those with clinical failure (ie, recurrent clinical symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    varicose veins) and can be classified as [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/26\">",
"     26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nonocclusion &ndash; Type I anatomic failure refers to veins that failed to occlude initially and never occluded during follow-up.",
"     </li>",
"     <li>",
"      Recanalization &ndash; Type II anatomic failure refers to veins that were initially occluded but recanalized either partially or completely.",
"     </li>",
"     <li>",
"      Groin reflux &ndash; Type III anatomic failure refers to the situation in which the vein trunk was occluded but reflux is detected in the groin region. This type of failure often involves an accessory saphenous vein.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Other issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although uncommon, the loss of radiographic",
"    <span class=\"nowrap\">",
"     guidewires/sheath",
"    </span>",
"    components into the circulation has been reported. Ensuring that wires are at least twice the length of the",
"    <span class=\"nowrap\">",
"     catheter/sheath",
"    </span>",
"    into which they are introduced, minimizes the likelihood of this complication.",
"   </p>",
"   <p>",
"    Device components should be examined carefully after they are removed from the patient to insure their integrity. If there is any question about the possible loss of a device, radiographs should be obtained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     VEIN CLOSURE RATES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Closure rates with radiofrequency ablation have improved with operator experience and newer technologies. Immediate closure rates of the saphenous vein are higher than for perforator veins (&gt;90 versus 70-80 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/20,27-32\">",
"     20,27-32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Saphenous",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two meta-analyses evaluating anatomic vein closure using continuous pullback catheters found immediate closure rates between 89 and 94 percent for great saphenous ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/31,33\">",
"     31,33",
"    </a>",
"    ]. However, re-opening of the previously occluded vein occurred in 15 to 19 percent of veins at three years and in 26 to 30 percent of veins at three to five years follow-up. Alterations in closure technique, increasing probe temperature (VNUS Closure&trade;, 90&ordm;C; ClosureFast&trade;, 120&ordm;C) and increased ablation time, have led to immediate occlusion rates as high as 99.6 percent; however, long-term data are not available for newer generation devices [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Immediate closure rates for the small saphenous vein are similar to those of the great saphenous vein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Perforators",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immediate occlusion of perforator veins following RFA occurs in 70 to 80 percent of treated veins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/20,32\">",
"     20,32",
"    </a>",
"    ]. In one prospective study, at five years follow-up recurrent reflux developed in 19 percent of perforators previously confirmed closed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/19\">",
"     19",
"    </a>",
"    ]. Interestingly, of the total number of perforators identified with reflux, 19 percent were new [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     CLINICAL OUTCOMES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Resumption of normal activities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple randomized trials have shown that immediate postoperative quality of life measures (pain, ecchymosis, tenderness) are significantly better following treatment of the saphenous vein using RFA compared with surgical stripping or endovenous laser ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/12,36-40\">",
"     12,36-40",
"    </a>",
"    ], although some newer laser wavelengths (eg, 1470 nm) are associated with fewer postoperative symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/41\">",
"     41",
"    </a>",
"    ]. The low incidence of adverse effects and complications with RFA results in a significantly lower number of days to return to normal activities and work compared with vein stripping (1.5 versus 3.9 days, 4.7 versus 12.4 days) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/12,36\">",
"     12,36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Venous clinical severity scale",
"    </span>",
"    &nbsp;&mdash;&nbsp;Improvement in symptoms and appearance of varicose veins as reflected by venous clinical severity scales (VCSS) are significantly improved following RFA of the saphenous vein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/12,28,42\">",
"     12,28,42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/29/11735?source=see_link\">",
"     \"Classification of lower extremity chronic venous disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Improvement in venous clinical severity scores can occur in spite of anatomic failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/3,28\">",
"     3,28",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H31\">",
"     'Anatomic failure'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H33\">",
"     'Vein closure rates'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In a retrospective review, the VCSS in 256 extremities improved from 3.9 &plusmn; 2.1 before radiofrequency ablation of the great saphenous vein to 0.9 &plusmn; 1.5 at three months, and the VCSS was maintained at &lt;1.0 for up to two years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Recurrent varicose veins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Up to one-third of patients treated with saphenous stripping have residual or recurrent varicose veins. A small randomized trial (n = 30 patients) found no significant difference in varicose vein recurrence between saphenous stripping and RFA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Venous ulcer healing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical trials have demonstrated that saphenous stripping reduces ulcer recurrence rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]. It has been assumed that successful application of other means of eliminating reflux in the saphenous vein (endovenous ablation, sclerotherapy) should lead to similar results; however, there are no randomized trials comparing techniques.",
"   </p>",
"   <p>",
"    Recurrence of reflux in perforator veins following the management of saphenous reflux is a risk factor for venous ulcer nonhealing or recurrence. For this reason, treatment of refluxing perforators may be beneficial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/43,46\">",
"     43,46",
"    </a>",
"    ]. Minimally invasive techniques including RFA are associated with fewer complications compared with surgical management of perforators (ie, SEPS). However, standardization of the radiofrequency perforator ablation technique and clinical trials comparing RFA with other therapies for the management of venous ulceration are needed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/19,47\">",
"     19,47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one retrospective review of 356 patients who underwent radiofrequency ablation, there were no significant differences in ulcer healing or ulcer recurrence rates whether the greater saphenous vein was treated in isolation or in combination with radiofrequency perforator ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/5/30809/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Radiofrequency ablation (RFA) is a minimally invasive percutaneous technique using thermal energy to ablate incompetent veins. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radiofrequency ablation devices transmit a high frequency alternating current through an electrode which heats the vein wall altering its intrinsic protein structure and effecting closure of the vein. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Radiofrequency devices'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Candidates for radiofrequency ablation are patients with persistent",
"      <span class=\"nowrap\">",
"       symptoms/signs",
"      </span>",
"      of venous disease after a minimum of three months of medical therapy plus documented reflux (ie, retrograde flow &gt;0.5 second duration) as a source of their symptoms. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radiofrequency ablation is used primarily to treat venous insufficiency of the axial veins (ie, great, small, or accessory saphenous veins). Specialized probes are available to treat perforating veins. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radiofrequency ablation is performed in an office-based or ambulatory surgery setting with local tumescent anesthetic and mild sedation, as needed. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A follow-up duplex ultrasound is performed within two to three days of the procedure to evaluate the presence of deep venous thrombosis. We repeat duplex ultrasound within a week if thrombus is identified at the",
"      <span class=\"nowrap\">",
"       saphenofemoral/saphenopopliteal",
"      </span>",
"      junction, extending up to, but not into, the deep vein. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Postoperative duplex ultrasound'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications following radiofrequency ablation are uncommon and include nerve injury, and superficial or deep venous thrombosis. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Complications'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/25/43417?source=see_link\">",
"       \"Superficial thrombophlebitis of the lower extremity\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link\">",
"       \"Treatment of lower extremity deep vein thrombosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/1\">",
"      Khaira HS, Parnell A. Colour flow duplex in the assessment of varicose veins. Clin Radiol 1995; 50:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/2\">",
"      Smith JJ, Brown L, Greenhalgh RM, Davies AH. Randomised trial of pre-operative colour duplex marking in primary varicose vein surgery: outcome is not improved. Eur J Vasc Endovasc Surg 2002; 23:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/3\">",
"      Merchant RF, Pichot O, Closure Study Group. Long-term outcomes of endovenous radiofrequency obliteration of saphenous reflux as a treatment for superficial venous insufficiency. J Vasc Surg 2005; 42:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/4\">",
"      Dayan V, Cura L, Cubas S, Carriquiry G. Surgical anatomy of the saphenous nerve. Ann Thorac Surg 2008; 85:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/5\">",
"      Theivacumar NS, Gough MJ. Influence of warfarin on the success of endovenous laser ablation (EVLA) of the great saphenous vein (GSV). Eur J Vasc Endovasc Surg 2009; 38:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/6\">",
"      Sharifi M, Mehdipour M, Bay C, et al. Effect of anticoagulation on endothermal ablation of the great saphenous vein. J Vasc Surg 2011; 53:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/7\">",
"      Gale SS, Dosick SM, Seiwert AJ, Comerota AJ. Regarding \"Deep venous thrombosis after radiofrequency ablation of greater saphenous vein\". J Vasc Surg 2005; 41:374; author reply 374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/8\">",
"      Subramonia S, Lees T. Regarding \"Deep vein thrombosis after radiofrequency ablation of greater saphenous vein: A word of caution\". J Vasc Surg 2005; 41:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/9\">",
"      Pichot O, Kabnick LS, Creton D, et al. Duplex ultrasound scan findings two years after great saphenous vein radiofrequency endovenous obliteration. J Vasc Surg 2004; 39:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/10\">",
"      Monahan DL. Can phlebectomy be deferred in the treatment of varicose veins? J Vasc Surg 2005; 42:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/11\">",
"      Welch HJ. Endovenous ablation of the great saphenous vein may avert phlebectomy for branch varicose veins. J Vasc Surg 2006; 44:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/12\">",
"      Almeida JI, Kaufman J, G&ouml;ckeritz O, et al. Radiofrequency endovenous ClosureFAST versus laser ablation for the treatment of great saphenous reflux: a multicenter, single-blinded, randomized study (RECOVERY study). J Vasc Interv Radiol 2009; 20:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/13\">",
"      Pichot O, Sessa C, Chandler JG, et al. Role of duplex imaging in endovenous obliteration for primary venous insufficiency. J Endovasc Ther 2000; 7:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/14\">",
"      Defty C, Eardley N, Taylor M, et al. A comparison of the complication rates following unilateral and bilateral varicose vein surgery. Eur J Vasc Endovasc Surg 2008; 35:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/15\">",
"      Janne d'Oth&eacute;e B, Faintuch S, Schirmang T, Lang EV. Endovenous laser ablation of the saphenous veins: bilateral versus unilateral single-session procedures. J Vasc Interv Radiol 2008; 19:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/16\">",
"      Chong PFS, Kumar R, Kushwaha R, et, al. Technical tip: cold saline infiltration instead of local anaesthetic in endovenous laser treatment. Phlebology  2006; 21:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/17\">",
"      Lawrence PF, Chandra A, Wu M, et al. Classification of proximal endovenous closure levels and treatment algorithm. J Vasc Surg 2010; 52:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/18\">",
"      Bush RG, Shamma HN, Hammond K. Histological changes occurring after endoluminal ablation with two diode lasers (940 and 1319 nm) from acute changes to 4 months. Lasers Surg Med 2008; 40:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/19\">",
"      Bacon JL, Dinneen AJ, Marsh P, et al. Five-year results of incompetent perforator vein closure using TRans-Luminal Occlusion of Perforator. Phlebology 2009; 24:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/20\">",
"      Peden E, Lumsden A. Radiofrequency ablation of incompetent perforator veins. Perspect Vasc Surg Endovasc Ther 2007; 19:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/21\">",
"      Mozes G, Kalra M, Carmo M, et al. Extension of saphenous thrombus into the femoral vein: a potential complication of new endovenous ablation techniques. J Vasc Surg 2005; 41:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/22\">",
"      Fassiadis N, Kianifard B, Holdstock JM, Whiteley MS. Ultrasound changes at the saphenofemoral junction and in the long saphenous vein during the first year after VNUS closure. Int Angiol 2002; 21:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/23\">",
"      Leon L, Giannoukas AD, Dodd D, et al. Clinical significance of superficial vein thrombosis. Eur J Vasc Endovasc Surg 2005; 29:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/24\">",
"      Merchant R Jr, Kistner RL, Kabnick LS. Is there an increased risk for DVT with the VNUS closure procedure? J Vasc Surg 2003; 38:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/25\">",
"      Hingorani AP, Ascher E, Markevich N, et al. Deep venous thrombosis after radiofrequency ablation of greater saphenous vein: a word of caution. J Vasc Surg 2004; 40:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/26\">",
"      Khilnani NM, Grassi CJ, Kundu S, et al. Multi-society consensus quality improvement guidelines for the treatment of lower-extremity superficial venous insufficiency with endovenous thermal ablation from the Society of Interventional Radiology, Cardiovascular Interventional Radiological Society of Europe, American College of Phlebology and Canadian Interventional Radiology Association. J Vasc Interv Radiol 2010; 21:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/27\">",
"      Puggioni A, Kalra M, Carmo M, et al. Endovenous laser therapy and radiofrequency ablation of the great saphenous vein: analysis of early efficacy and complications. J Vasc Surg 2005; 42:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/28\">",
"      Merchant RF, DePalma RG, Kabnick LS. Endovascular obliteration of saphenous reflux: a multicenter study. J Vasc Surg 2002; 35:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/29\">",
"      Manfrini S, Gasbarro V, Danielsson G, et al. Endovenous management of saphenous vein reflux. Endovenous Reflux Management Study Group. J Vasc Surg 2000; 32:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/30\">",
"      Lurie F, Creton D, Eklof B, et al. Prospective randomised study of endovenous radiofrequency obliteration (closure) versus ligation and vein stripping (EVOLVeS): two-year follow-up. Eur J Vasc Endovasc Surg 2005; 29:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/31\">",
"      Luebke T, Brunkwall J. Systematic review and meta-analysis of endovenous radiofrequency obliteration, endovenous laser therapy, and foam sclerotherapy for primary varicosis. J Cardiovasc Surg (Torino) 2008; 49:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/32\">",
"      van Rij AM, Hill G, Gray C, et al. A prospective study of the fate of venous leg perforators after varicose vein surgery. J Vasc Surg 2005; 42:1156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/33\">",
"      van den Bos R, Arends L, Kockaert M, et al. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg 2009; 49:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/34\">",
"      Proebstle TM, Vago B, Alm J, et al. Treatment of the incompetent great saphenous vein by endovenous radiofrequency powered segmental thermal ablation: first clinical experience. J Vasc Surg 2008; 47:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/35\">",
"      Per&auml;l&auml; J, Rautio T, Biancari F, et al. Radiofrequency endovenous obliteration versus stripping of the long saphenous vein in the management of primary varicose veins: 3-year outcome of a randomized study. Ann Vasc Surg 2005; 19:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/36\">",
"      Lurie F, Creton D, Eklof B, et al. Prospective randomized study of endovenous radiofrequency obliteration (closure procedure) versus ligation and stripping in a selected patient population (EVOLVeS Study). J Vasc Surg 2003; 38:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/37\">",
"      Goode SD, Chowdhury A, Crockett M, et al. Laser and radiofrequency ablation study (LARA study): a randomised study comparing radiofrequency ablation and endovenous laser ablation (810 nm). Eur J Vasc Endovasc Surg 2010; 40:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/38\">",
"      Shepherd AC, Gohel MS, Brown LC, et al. Randomized clinical trial of VNUS ClosureFAST radiofrequency ablation versus laser for varicose veins. Br J Surg 2010; 97:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/39\">",
"      Gale SS, Lee JN, Walsh ME, et al. A randomized, controlled trial of endovenous thermal ablation using the 810-nm wavelength laser and the ClosurePLUS radiofrequency ablation methods for superficial venous insufficiency of the great saphenous vein. J Vasc Surg 2010; 52:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/40\">",
"      Nordon IM, Hinchliffe RJ, Brar R, et al. A prospective double-blind randomized controlled trial of radiofrequency versus laser treatment of the great saphenous vein in patients with varicose veins. Ann Surg 2011; 254:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/41\">",
"      Almeida J, Mackay E, Javier J, et al. Saphenous laser ablation at 1470 nm targets the vein wall, not blood. Vasc Endovascular Surg 2009; 43:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/42\">",
"      Proebstle TM, Alm J, G&ouml;ckeritz O, et al. Three-year European follow-up of endovenous radiofrequency-powered segmental thermal ablation of the great saphenous vein with or without treatment of calf varicosities. J Vasc Surg 2011; 54:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/43\">",
"      O'Donnell TF Jr. The present status of surgery of the superficial venous system in the management of venous ulcer and the evidence for the role of perforator interruption. J Vasc Surg 2008; 48:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/44\">",
"      Stuart WP, Adam DJ, Allan PL, et al. Saphenous surgery does not correct perforator incompetence in the presence of deep venous reflux. J Vasc Surg 1998; 28:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/45\">",
"      Kianifard B, Holdstock J, Allen C, et al. Randomized clinical trial of the effect of adding subfascial endoscopic perforator surgery to standard great saphenous vein stripping. Br J Surg 2007; 94:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/46\">",
"      Tenbrook JA Jr, Iafrati MD, O'donnell TF Jr, et al. Systematic review of outcomes after surgical management of venous disease incorporating subfascial endoscopic perforator surgery. J Vasc Surg 2004; 39:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/47\">",
"      van den Bos RR, Wentel T, Neumann MH, Nijsten T. Treatment of incompetent perforating veins using the radiofrequency ablation stylet: a pilot study. Phlebology 2009; 24:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/5/30809/abstract/48\">",
"      Marrocco CJ, Atkins MD, Bohannon WT, et al. Endovenous ablation for the treatment of chronic venous insufficiency and venous ulcerations. World J Surg 2010; 34:2299.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8203 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-60.18.131.125-4DC6258CCE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30809=[""].join("\n");
var outline_f30_5_30809=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H41\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CONTRAINDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Venous anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Saphenous nerve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Sural nerve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      RADIOFREQUENCY DEVICES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PREOPERATIVE ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Antibiotic prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DVT prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Patient counseling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Compression stockings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Follow-up duplex appointment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Vein mapping/marking",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      PROCEDURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Preparation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3107736\">",
"      - Equipment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3107753\">",
"      - Medications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3107760\">",
"      - Materials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      General technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Specific anatomic considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      FOLLOW-UP CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Pain management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Patient instructions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Postoperative duplex ultrasound",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      LOCAL ADVERSE REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Superficial thrombophlebitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Nerve injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Deep venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Technical complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Anatomic failure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Other issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      VEIN CLOSURE RATES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Saphenous",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Perforators",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      CLINICAL OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Resumption of normal activities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Venous clinical severity scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Recurrent varicose veins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Venous ulcer healing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/8203\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8203|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/46/36579\" title=\"figure 1A\">",
"      Superficial veins of leg anterior view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/42/42671\" title=\"figure 1B\">",
"      Superficial veins of lower leg posterior view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?42/56/43906\" title=\"figure 2\">",
"      Deep veins of the lower extremity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/17/272\" title=\"figure 3\">",
"      Sural nerve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8203|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?36/42/37547\" title=\"table 1\">",
"      Compression stockings in chronic venous disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/29/11735?source=related_link\">",
"      Classification of lower extremity chronic venous disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/31/30201?source=related_link\">",
"      Clinical features, diagnosis, and natural history of lower extremity peripheral artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/34/30250?source=related_link\">",
"      Endovenous laser ablation for the treatment of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/40/17031?source=related_link\">",
"      Laser and light therapy of lower extremity telangiectasias, reticular veins and small varicose veins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/12/13514?source=related_link\">",
"      Liquid and foam sclerotherapy techniques for the treatment of lower extremity veins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/50/35626?source=related_link\">",
"      Management of anticoagulation before and after elective surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/12/23752?source=related_link\">",
"      Management of inherited thrombophilia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/41/32410?source=related_link\">",
"      Medical management of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/29/21977?source=related_link\">",
"      Open surgical techniques for lower extremity vein ablation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/45/34521?source=related_link\">",
"      Overview and management of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19817?source=related_link\">",
"      Overview of anesthesia and anesthetic choices",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/25/43417?source=related_link\">",
"      Superficial thrombophlebitis of the lower extremity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=related_link\">",
"      Treatment of lower extremity deep vein thrombosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_5_30810="Normal liver - low power Masson trichrome stain";
var content_f30_5_30810=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F82380&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F82380&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    Normal liver (low power, Masson trichrome stain, Carnoy's fixative)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 728px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Liver cell plates and sinusoids make up more than 95 percent of the specimen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30810=[""].join("\n");
var outline_f30_5_30810=null;
var title_f30_5_30811="Classification of thymic tumors";
var content_f30_5_30811=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F73323&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F73323&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification of thymic epithelial tumors",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Levine and Rosai*",
"       </td>",
"       <td class=\"subtitle1\">",
"        M&uuml;ller-Hermelink, et",
"al&bull;",
"       </td>",
"       <td class=\"subtitle1\">",
"        WHO&Delta;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thymoma",
"       </td>",
"       <td>",
"        Thymoma",
"       </td>",
"       <td>",
"        Thymoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Encapsulated",
"       </td>",
"       <td>",
"        Medullary type",
"       </td>",
"       <td>",
"        Type A",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mixed type",
"       </td>",
"       <td>",
"        Type AB",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Malignant",
"type I (invasive)",
"       </td>",
"       <td>",
"        Predominantly cortical",
"       </td>",
"       <td>",
"        Type B1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cortical",
"type",
"       </td>",
"       <td>",
"        Type B2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Well differentiated carcinoma",
"       </td>",
"       <td>",
"        Type B3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Malignant type II",
"       </td>",
"       <td>",
"        Thymic",
"carcinoma",
"       </td>",
"       <td>",
"        Thymic carcinoma (Type C thymoma)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     * Levine, GD, Rosai, J. Hum Pathol 1978; 9:495.",
"     <br>",
"      &bull; Marino, M, M&uuml;ller-Hermelink, HK. Virchows Arch A Pathol Anat Histopathol 1985; 407:119.",
"      <br>",
"       &Delta; Rosai, J. Histological Typing of Tumours of the Thymus, 2nd ed, Springer, Berlin, 1999.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30811=[""].join("\n");
var outline_f30_5_30811=null;
var title_f30_5_30812="Diagnostic yield of screening for chromosomal anomalies in ID";
var content_f30_5_30812=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72211&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72211&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Yield of screening for chromosomal anomalies in individuals with intellectual disability",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Population tested",
"       </td>",
"       <td class=\"subtitle1\">",
"        Diagnostic yield*",
"        <br/>",
"        (percent of patients with positive results)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Chromosomal microarray analysis (CMA)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Unexplained GDD/ID",
"       </td>",
"       <td>",
"        15 to 20",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td>",
"        CMA is recommended as first-line test for most patients with GDD/ID, unless the patient has features suggesting a specific disorder, as described below.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Chromosomal karyotype",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Unexplained GDD/ID without syndromic features",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td rowspan=\"2\">",
"        Recommended as first-line test for the following:",
"        <ul>",
"         <li>",
"          Patients with features of Down or other chromosomal syndrome",
"         </li>",
"         <li>",
"          Family history of chromosomal abnormalities",
"         </li>",
"         <li>",
"          Parent with multiple miscarriages",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Syndromic GDD/ID",
"       </td>",
"       <td>",
"        19",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Subtelomeric fluorescence in situ hybridization (StFISH)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Unexplained GDD/ID or MCA",
"       </td>",
"       <td>",
"        4 to 6",
"       </td>",
"       <td rowspan=\"2\">",
"        Where available, microarray analysis is generally recommended to replace StFISH testing.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mild GDD/ID",
"       </td>",
"       <td>",
"        1 to 2",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     GDD: global developmental delay; ID: intellectual disability; MCA: multiple congenital anomalies; XL: X-linked.",
"     <br>",
"      * Represents approximate diagnostic yield, based on a meta-analysis of population studies. Most of the included studies were \"class III,\" defined as a sample of patients studied during the course of a condition, rather than a population-based sample.",
"      <br>",
"       &Delta; Chromosomal microarray analysis (CMA) is also known as comparative genomic hybridization (CGH).",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86:749.",
"       </li>",
"      </ol>",
"      Data from: Michelson DJ, Shevell MI, Sherr EH, Moeschler JB, Gropman AL, Ashwal S. Evidence report: Genetic and metabolic testing on children with global developmental delay. Neurology 2011; 77:1629.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30812=[""].join("\n");
var outline_f30_5_30812=null;
var title_f30_5_30813="Contents: Rheumatology calculators";
var content_f30_5_30813=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?0/37/606\">",
"       Calculators",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Rheumatology calculators",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Rheumatology calculators",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Clinical Criteria",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/36/27205\">",
"           Calculator: Rheumatoid arthritis Clinical Disease Activity Index (CDAI)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/36/13894\">",
"           Calculator: Rheumatoid arthritis Disease Activity Score (DAS-28)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/51/39733\">",
"           Calculator: Rheumatoid arthritis Simplified Disease Activity Index (SDAI)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Medical Equations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/19/42288\">",
"           Calculator: Corticosteroid Medication Dosing Conversions (glucocorticoid effect)",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-3B6AEAD9A4-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f30_5_30813=[""].join("\n");
var outline_f30_5_30813=null;
var title_f30_5_30814="Fetal AFP levels by GA";
var content_f30_5_30814=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F65276&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F65276&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 492px\">",
"   <div class=\"ttl\">",
"    The relationship between alpha-fetoprotein (AFP) values in fetal serum and gestational age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 472px; height: 338px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data adapted from: Habib, ZA. Maternal Serum alpha-fetoprotein: Its value in antenatal diagnosis of genetic disease and in obstetrical-gynaecological care. Acta Obstet Gynecol Scand 1977;61:1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30814=[""].join("\n");
var outline_f30_5_30814=null;
var title_f30_5_30815="Standard cricothyrotomy step two";
var content_f30_5_30815=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F82644&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F82644&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Standard cricothyrotomy step two",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 372px; height: 322px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <font class=\"red\" color=\"black\">",
"     <font color=\"black\">",
"      Make a midline vertical skin incision, 3-5 cm in length.",
"     </font>",
"    </font>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Custalow CB. Color Atlas of Emergency Department Procedures, Elsevier Saunders, Philadelphia 2005. Copyright &copy;2005 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_5_30815=[""].join("\n");
var outline_f30_5_30815=null;
